Huntington's disease (English Wikipedia)

"Insurance Genetics Moratorium extended to 2017" (Press release). Association of British Insurers. 5 April 2011. Archived from the original on 4 March 2016. Retrieved 13 January 2016.

adisonline.com

Frank S, Jankovic J (March 2010). "Advances in the pharmacological management of Huntington's disease". Drugs. 70 (5): 561–571. doi:10.2165/11534430-000000000-00000. PMID 20329804. S2CID 42386743. Archived from the original on 8 October 2011.

archive.org

Passarge E (2001). Color Atlas of Genetics (2nd ed.). Thieme. p. 142. ISBN 978-0-86577-958-7.
Wexler A, Wexler N (2008). The Woman Who Walked Into the Sea. Huntington's and the Making of a Genetic Disease. Yale University Press. p. 288. ISBN 978-0-300-10502-5. Retrieved 15 November 2015.
Bateson W (1909). Mendel's Principles of Heredity. Cambridge, England: Cambridge University Press. p. 229. Bateson refers to "Huntington's disease" as "Hereditary Chorea".

bbc.co.uk

news.bbc.co.uk

"Expert backs gene test disclosure". BBC article. 7 June 2007. Archived from the original on 26 February 2008.

bbc.com

"Landmark Huntington's trial starts". Archived from the original on 21 October 2015. Retrieved 19 October 2015.

cam.ac.uk

repository.cam.ac.uk

Djajadikerta A, Keshri S, Pavel M, Prestil R, Ryan L, Rubinsztein DC (April 2020). "Autophagy Induction as a Therapeutic Strategy for Neurodegenerative Diseases". Journal of Molecular Biology. Autophagy in Neurodegenerative Diseases. 432 (8): 2799–2821. doi:10.1016/j.jmb.2019.12.035. PMID 31887286. S2CID 209518157. Archived from the original on 23 May 2022. Retrieved 20 June 2023.

chdifoundation.org

"Scientific Publications | CHDI Foundation". chdifoundation.org. Archived from the original on 12 December 2021. Retrieved 12 December 2021.
"CHDI Foundation". chdifoundation.org. Archived from the original on 14 November 2020. Retrieved 13 November 2020.

clevelandclinic.org

my.clevelandclinic.org

"Aspiration Pneumonia: What It Is, Causes, Diagnosis, Treatment". Cleveland Clinic. Archived from the original on 12 June 2023. Retrieved 12 June 2023.

clinicaltrials.gov

"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-HTTRx in Patients With Early Manifest Huntington's Disease - Full Text View". ClinicalTrials.gov. Archived from the original on 29 September 2015. Retrieved 18 April 2016.
"A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)".
"Search of: Huntington Disease - List Results - ClinicalTrials.gov". clinicaltrials.gov. Archived from the original on 11 November 2021. Retrieved 16 November 2020.

cma.ca

Montoya A, Price BH, Menear M, Lepage M (January 2006). "Brain imaging and cognitive dysfunctions in Huntington's disease" (PDF). Journal of Psychiatry & Neuroscience. 31 (1): 21–29. PMC 1325063. PMID 16496032. Archived from the original (PDF) on 23 March 2016. Retrieved 17 September 2008.

congress.gov

"US Senate s. resolution 531". S. Res. 531. US Senate. 6 April 2008. Archived from the original on 17 November 2015. Retrieved 10 August 2008.

doi.org

Dayalu P, Albin RL (February 2015). "Huntington disease: pathogenesis and treatment". Neurologic Clinics. 33 (1): 101–114. doi:10.1016/j.ncl.2014.09.003. PMID 25432725.
Frank S (January 2014). "Treatment of Huntington's disease". Neurotherapeutics. 11 (1): 153–160. doi:10.1007/s13311-013-0244-z. PMC 3899480. PMID 24366610.
Durr A, Gargiulo M, Feingold J (November 2012). "The presymptomatic phase of Huntington disease". Revue Neurologique. 168 (11): 806–808. doi:10.1016/j.neurol.2012.07.003. PMID 22902173.
Illarioshkin SN, Klyushnikov SA, Vigont VA, Seliverstov YA, Kaznacheyeva EV (September 2018). "Molecular Pathogenesis in Huntington's Disease". Biochemistry. Biokhimiia. 83 (9): 1030–1039. doi:10.1134/S0006297918090043. PMID 30472941. S2CID 26471825. Archived from the original on 13 November 2020. Retrieved 8 November 2020 – via protein.bio.msu.ru.
Sudhakar V, Richardson RM (January 2019). "Gene Therapy for Neurodegenerative Diseases". Neurotherapeutics. 16 (1): 166–175. doi:10.1007/s13311-018-00694-0. PMC 6361055. PMID 30542906.
Saudou F, Humbert S (March 2016). "The Biology of Huntingtin". Neuron. 89 (5): 910–926. doi:10.1016/j.neuron.2016.02.003. PMID 26938440. S2CID 8272667.
Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, et al. (April 2015). "Huntington disease". Nature Reviews. Disease Primers. 1: 15005. doi:10.1038/nrdp.2015.5. PMID 27188817. S2CID 25759303.
Vale TC, Cardoso F (2015). "Chorea: A Journey through History". Tremor and Other Hyperkinetic Movements. 5. doi:10.7916/D8WM1C98 (inactive 1 November 2024). PMC 4454991. PMID 26056609.{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)
Walker FO (January 2007). "Huntington's disease". Lancet. 369 (9557): 218–228. doi:10.1016/S0140-6736(07)60111-1. PMID 17240289. S2CID 46151626.
Dickey AS, La Spada AR (April 2018). "Therapy development in Huntington disease: From current strategies to emerging opportunities". American Journal of Medical Genetics. Part A. 176 (4): 842–861. doi:10.1002/ajmg.a.38494. PMC 5975251. PMID 29218782.
Aziz NA, van der Marck MA, Pijl H, Olde Rikkert MG, Bloem BR, Roos RA (December 2008). "Weight loss in neurodegenerative disorders". Journal of Neurology. 255 (12): 1872–1880. doi:10.1007/s00415-009-0062-8. PMID 19165531. S2CID 26109381.
van Duijn E, Kingma EM, van der Mast RC (2007). "Psychopathology in verified Huntington's disease gene carriers". The Journal of Neuropsychiatry and Clinical Neurosciences. 19 (4): 441–448. doi:10.1176/appi.neuropsych.19.4.441. PMID 18070848.
van der Burg JM, Björkqvist M, Brundin P (August 2009). "Beyond the brain: widespread pathology in Huntington's disease". The Lancet. Neurology. 8 (8): 765–774. doi:10.1016/S1474-4422(09)70178-4. PMID 19608102. S2CID 14419437.
Katsuno M, Banno H, Suzuki K, Takeuchi Y, Kawashima M, Tanaka F, et al. (May 2008). "Molecular genetics and biomarkers of polyglutamine diseases". Current Molecular Medicine. 8 (3): 221–234. doi:10.2174/156652408784221298. PMID 18473821.
Squitieri F, Frati L, Ciarmiello A, Lastoria S, Quarrell O (February 2006). "Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease?". Mechanisms of Ageing and Development. 127 (2): 208–212. doi:10.1016/j.mad.2005.09.012. PMID 16274727. S2CID 20523093.
Nance MA, Myers RH (2001). "Juvenile onset Huntington's disease--clinical and research perspectives". Mental Retardation and Developmental Disabilities Research Reviews. 7 (3): 153–157. doi:10.1002/mrdd.1022. PMID 11553930.
Ridley RM, Frith CD, Crow TJ, Conneally PM (September 1988). "Anticipation in Huntington's disease is inherited through the male line but may originate in the female". Journal of Medical Genetics. 25 (9): 589–595. doi:10.1136/jmg.25.9.589. PMC 1051535. PMID 2972838.
Semaka A, Creighton S, Warby S, Hayden MR (October 2006). "Predictive testing for Huntington disease: interpretation and significance of intermediate alleles". Clinical Genetics. 70 (4): 283–294. doi:10.1111/j.1399-0004.2006.00668.x. PMID 16965319. S2CID 26007984.
Wexler NS, Young AB, Tanzi RE, Travers H, Starosta-Rubinstein S, Penney JB, et al. (1987). "Homozygotes for Huntington's disease". Nature. 326 (6109): 194–197. Bibcode:1987Natur.326..194W. doi:10.1038/326194a0. hdl:2027.42/62543. PMID 2881213. S2CID 4312171.
Squitieri F, Gellera C, Cannella M, Mariotti C, Cislaghi G, Rubinsztein DC, et al. (April 2003). "Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course". Brain. 126 (Pt 4): 946–955. doi:10.1093/brain/awg077. PMID 12615650.
Goehler H, Lalowski M, Stelzl U, Waelter S, Stroedicke M, Worm U, et al. (September 2004). "A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease". Molecular Cell. 15 (6): 853–865. doi:10.1016/j.molcel.2004.09.016. PMID 15383276.
Glajch KE, Sadri-Vakili G (2015). "Epigenetic Mechanisms Involved in Huntington's Disease Pathogenesis". Journal of Huntington's Disease. 4 (1): 1–15. doi:10.3233/JHD-159001. PMID 25813218.
Liu Z, Zhou T, Ziegler AC, Dimitrion P, Zuo L (2017). "Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications". Oxidative Medicine and Cellular Longevity. 2017: 2525967. doi:10.1155/2017/2525967. PMC 5529664. PMID 28785371.
Cattaneo E, Zuccato C, Tartari M (December 2005). "Normal huntingtin function: an alternative approach to Huntington's disease". Nature Reviews. Neuroscience. 6 (12): 919–930. doi:10.1038/nrn1806. PMID 16288298. S2CID 10119487.
Rubinsztein DC, Carmichael J (August 2003). "Huntington's disease: molecular basis of neurodegeneration". Expert Reviews in Molecular Medicine. 5 (20): 1–21. doi:10.1017/S1462399403006549. PMID 14585171. S2CID 28435830.
Matlahov I, van der Wel PC (December 2019). "Conformational studies of pathogenic expanded polyglutamine protein deposits from Huntington's disease". Experimental Biology and Medicine. 244 (17): 1584–1595. doi:10.1177/1535370219856620. PMC 6920524. PMID 31203656. S2CID 189944779.
Sadri-Vakili G, Cha JH (June 2006). "Mechanisms of disease: Histone modifications in Huntington's disease". Nature Clinical Practice. Neurology. 2 (6): 330–338. doi:10.1038/ncpneuro0199. PMID 16932577. S2CID 12474262.
Kumar A, Ratan RR (October 2016). "Oxidative Stress and Huntington's Disease: The Good, The Bad, and The Ugly". Journal of Huntington's Disease. 5 (3): 217–237. doi:10.3233/JHD-160205. PMC 5310831. PMID 27662334.
Nopoulos PC (March 2016). "Huntington disease: a single-gene degenerative disorder of the striatum". Dialogues in Clinical Neuroscience. 18 (1): 91–98. doi:10.31887/DCNS.2016.18.1/pnopoulos. PMC 4826775. PMID 27069383.
McColgan P, Tabrizi SJ (January 2018). "Huntington's disease: a clinical review". European Journal of Neurology. 25 (1): 24–34. doi:10.1111/ene.13413. PMID 28817209.
Lobsiger CS, Cleveland DW (November 2007). "Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease". Nature Neuroscience. 10 (11): 1355–1360. doi:10.1038/nn1988. PMC 3110080. PMID 17965655.
Crossman AR (May 2000). "Functional anatomy of movement disorders". Journal of Anatomy. 196 (Pt 4): 519–525. doi:10.1046/j.1469-7580.2000.19640519.x. PMC 1468094. PMID 10923984.
Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, et al. (October 2001). "Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila". Nature. 413 (6857): 739–743. Bibcode:2001Natur.413..739S. doi:10.1038/35099568. PMID 11607033. S2CID 4419980. Archived from the original on 1 August 2020. Retrieved 28 June 2019.
Petruska J, Hartenstine MJ, Goodman MF (February 1998). "Analysis of strand slippage in DNA polymerase expansions of CAG/CTG triplet repeats associated with neurodegenerative disease". The Journal of Biological Chemistry. 273 (9): 5204–5210. doi:10.1074/jbc.273.9.5204. PMID 9478975.
Rao AK, Muratori L, Louis ED, Moskowitz CB, Marder KS (April 2009). "Clinical measurement of mobility and balance impairments in Huntington's disease: validity and responsiveness". Gait & Posture. 29 (3): 433–436. doi:10.1016/j.gaitpost.2008.11.002. PMID 19111470.
Myers RH (April 2004). "Huntington's disease genetics". NeuroRx. 1 (2): 255–262. doi:10.1602/neurorx.1.2.255. PMC 534940. PMID 15717026.
de Die-Smulders CE, de Wert GM, Liebaers I, Tibben A, Evers-Kiebooms G (May 2013). "Reproductive options for prospective parents in families with Huntington's disease: clinical, psychological and ethical reflections". Human Reproduction Update. 19 (3): 304–315. doi:10.1093/humupd/dms058. PMID 23377865. de Die-Smulders CE, de Wert GM, Liebaers I, Tibben A, Evers-Kiebooms G (2013). "Reproductive options for prospective parents in families with Huntington's disease: clinical, psychological and ethical reflections". Human Reproduction Update. 19 (3): 304–315. doi:10.1093/humupd/dms058. PMID 23377865.
Baig SS, Strong M, Rosser E, Taverner NV, Glew R, Miedzybrodzka Z, et al. (October 2016). "22 Years of predictive testing for Huntington's disease: the experience of the UK Huntington's Prediction Consortium". European Journal of Human Genetics. 24 (10): 1396–1402. doi:10.1038/ejhg.2016.36. PMC 5027682. PMID 27165004.
Forrest Keenan K, Simpson SA, Miedzybrodzka Z, Alexander DA, Semper J (June 2013). "How do partners find out about the risk of Huntington's disease in couple relationships?". Journal of Genetic Counseling. 22 (3): 336–344. doi:10.1007/s10897-012-9562-2. PMID 23297124. S2CID 15447709.
Erwin C, Williams JK, Juhl AR, Mengeling M, Mills JA, Bombard Y, et al. (July 2010). "Perception, experience, and response to genetic discrimination in Huntington disease: the international RESPOND-HD study". American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics. 153B (5): 1081–1093. doi:10.1002/ajmg.b.31079. PMC 3593716. PMID 20468061.
Burson CM, Markey KR (September 2001). "Genetic counseling issues in predictive genetic testing for familial adult-onset neurologic diseases". Seminars in Pediatric Neurology. 8 (3): 177–186. doi:10.1053/spen.2001.26451. PMID 11575847.
Smith JA, Michie S, Stephenson M, Quarrell O (March 2002). "Risk Perception and Decision-making Processes in Candidates for Genetic Testing for Huntington's Disease: An Interpretative Phenomenological Analysis". Journal of Health Psychology. 7 (2): 131–144. doi:10.1177/1359105302007002398. PMID 22114233. S2CID 40182214.
Hayden MR (March 2003). "Predictive testing for Huntington's disease: a universal model?". The Lancet. Neurology. 2 (3): 141–142. doi:10.1016/S1474-4422(03)00317-X. PMID 12849232. S2CID 39581496.
"Guidelines for the molecular genetics predictive test in Huntington's disease. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea". Neurology. 44 (8): 1533–1536. August 1994. doi:10.1212/WNL.44.8.1533. PMID 8058167. S2CID 28018134.
Losekoot M, van Belzen MJ, Seneca S, Bauer P, Stenhouse SA, Barton DE (May 2013). "EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease". European Journal of Human Genetics. 21 (5): 480–486. doi:10.1038/ejhg.2012.200. PMC 3641377. PMID 22990145.
Schulman JD, Black SH, Handyside A, Nance WE (February 1996). "Preimplantation genetic testing for Huntington disease and certain other dominantly inherited disorders". Clinical Genetics. 49 (2): 57–58. doi:10.1111/j.1399-0004.1996.tb04327.x. PMID 8740912. S2CID 45703511.
Stern HJ, Harton GL, Sisson ME, Jones SL, Fallon LA, Thorsell LP, et al. (June 2002). "Non-disclosing preimplantation genetic diagnosis for Huntington disease". Prenatal Diagnosis. 22 (6): 503–507. doi:10.1002/pd.359. PMID 12116316. S2CID 33967835.
Kuliev A, Verlinsky Y (April 2005). "Preimplantation diagnosis: a realistic option for assisted reproduction and genetic practice". Current Opinion in Obstetrics & Gynecology. 17 (2): 179–183. doi:10.1097/01.gco.0000162189.76349.c5. PMID 15758612. S2CID 9382420.
Schneider SA, Walker RH, Bhatia KP (September 2007). "The Huntington's disease-like syndromes: what to consider in patients with a negative Huntington's disease gene test". Nature Clinical Practice. Neurology. 3 (9): 517–525. doi:10.1038/ncpneuro0606. PMID 17805246. S2CID 9052603.
Frank S, Jankovic J (March 2010). "Advances in the pharmacological management of Huntington's disease". Drugs. 70 (5): 561–571. doi:10.2165/11534430-000000000-00000. PMID 20329804. S2CID 42386743. Archived from the original on 8 October 2011.
Bonelli RM, Wenning GK, Kapfhammer HP (March 2004). "Huntington's disease: present treatments and future therapeutic modalities". International Clinical Psychopharmacology. 19 (2): 51–62. doi:10.1097/00004850-200403000-00001. PMID 15076012. S2CID 1956458.
Panagiotakis PH, DiSario JA, Hilden K, Ogara M, Fang JC (2008). "DPEJ tube placement prevents aspiration pneumonia in high-risk patients". Nutrition in Clinical Practice. 23 (2): 172–175. doi:10.1177/0884533608314537. PMID 18390785.
Quin L, Busee M (February 2012). "Development of physiotherapy guidance and treatment-based classifications for people with Huntington's disease". Neurodegenerative Disease Management. 2 (1): 21–31. doi:10.2217/nmt.11.86. Archived from the original on 9 August 2020. Retrieved 10 May 2012.
Khalil H, Quinn L, van Deursen R, Martin R, Rosser A, Busse M (January 2012). "Adherence to use of a home-based exercise DVD in people with Huntington disease: participants' perspectives". Physical Therapy. 92 (1): 69–82. doi:10.2522/ptj.20100438. PMID 21960468.
Travers E, Jones K, Nichol J (March 2007). "Palliative care provision in Huntington's disease". International Journal of Palliative Nursing. 13 (3): 125–130. doi:10.12968/ijpn.2007.13.3.23274. PMID 17505405.
Coppen EM, Roos RA (January 2017). "Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease". Drugs. 77 (1): 29–46. doi:10.1007/s40265-016-0670-4. PMC 5216093. PMID 27988871.
Morsy S, Khalil SM, Doheim MF, Kamel MG, El-Basiony DS, Ahmed Hassan HI, et al. (August 2019). "Efficacy of ethyl-EPA as a treatment for Huntington disease: a systematic review and meta-analysis". Acta Neuropsychiatrica. 31 (4): 175–185. doi:10.1017/neu.2019.11. hdl:10069/39427. PMID 30890195. S2CID 84183892.
Llamas E, Koyuncu S, Lee HJ, Wehrmann M, Gutierrez-Garcia R, Dunken N, et al. (November 2023). "In planta expression of human polyQ-expanded huntingtin fragment reveals mechanisms to prevent disease-related protein aggregation". Nature Aging. 3 (11): 1345–1357. doi:10.1038/s43587-023-00502-1. PMC 10645592. PMID 37783816.
A'Campo LE, Spliethoff-Kamminga NG, Roos RA (2012). "The Patient Education Program for Huntington's Disease (PEP-HD)". J Huntingtons Dis. 1 (1): 47–56. doi:10.3233/JHD-2012-120002. PMID 25063190.
Harper PS (June 1999). "Huntington's disease: a clinical, genetic and molecular model for polyglutamine repeat disorders". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 354 (1386): 957–61. doi:10.1098/rstb.1999.0446. PMC 1692597. PMID 10434293.
Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, et al. (August 1993). "The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease". Nature Genetics. 4 (4): 398–403. doi:10.1038/ng0893-398. PMID 8401589. S2CID 20645822.
Walker FO (January 2007). "Huntington's disease". Lancet. 369 (9557): 218–28. doi:10.1016/S0140-6736(07)60111-1. PMID 17240289. S2CID 46151626.
Di Maio L, Squitieri F, Napolitano G, Campanella G, Trofatter JA, Conneally PM (April 1993). "Suicide risk in Huntington's disease". Journal of Medical Genetics. 30 (4): 293–5. doi:10.1136/jmg.30.4.293. PMC 1016335. PMID 8487273.
Evans SJ, Douglas I, Rawlins MD, Wexler NS, Tabrizi SJ, Smeeth L (October 2013). "Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records". Journal of Neurology, Neurosurgery, and Psychiatry. 84 (10): 1156–60. doi:10.1136/jnnp-2012-304636. PMC 3786631. PMID 23482661.
Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, et al. (1983). "A polymorphic DNA marker genetically linked to Huntington's disease". Nature. 306 (5940): 234–8. Bibcode:1983Natur.306..234G. doi:10.1038/306234a0. PMID 6316146. S2CID 4320711.
Squitieri F, Andrew SE, Goldberg YP, Kremer B, Spence N, Zeisler J, et al. (December 1994). "DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence". Human Molecular Genetics. 3 (12): 2103–14. doi:10.1093/hmg/3.12.2103. PMID 7881406.
Sveinsson O, Halldórsson S, Olafsson E (July 2012). "An unusually low prevalence of Huntington's disease in Iceland". European Neurology. 68 (1): 48–51. doi:10.1159/000337680. PMID 22722209. S2CID 207551998.
Sipilä JO, Hietala M, Siitonen A, Päivärinta M, Majamaa K (January 2015). "Epidemiology of Huntington's disease in Finland". Parkinsonism & Related Disorders. 21 (1): 46–9. doi:10.1016/j.parkreldis.2014.10.025. PMID 25466405.
Almqvist EW, Elterman DS, MacLeod PM, Hayden MR (September 2001). "High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia". Clinical Genetics. 60 (3): 198–205. doi:10.1034/j.1399-0004.2001.600305.x. PMID 11595021. S2CID 19786394.
Lanska DJ (April 2000). "George Huntington (1850–1916) and hereditary chorea". Journal of the History of the Neurosciences. 9 (1): 76–89. doi:10.1076/0964-704X(200004)9:1;1-2;FT076. PMID 11232352. S2CID 22659368.
Brody IA, Wilkins RH (September 1967). "Huntington's chorea". Archives of Neurology. 17 (3): 331. doi:10.1001/archneur.1967.00470270109013. PMID 4228262.
Jelliffe SE, Muncey EB, Davenport CB (1913). "Huntington's Chorea: A Study in Heredity". The Journal of Nervous and Mental Disease. 40 (12): 796–799. doi:10.1097/00005053-191312000-00010. Archived from the original on 5 April 2022. Retrieved 19 September 2020.
Davenport CB, Muncey EB (1916). "Huntington's chorea in relation to heredity and eugenics". American Journal of Insanity. 73 (2): 195–222. doi:10.1176/ajp.73.2.195.
Vessie PR (1932). "On the transmission of Huntington's chorea for 300 years – the Bures family group". Nervous and Mental Disease. 76 (6): 553–573. doi:10.1097/00005053-193212000-00001. S2CID 147656032. Archived from the original on 28 August 2021. Retrieved 1 April 2009.
Wexler AR (2002). "Chorea and community in a nineteenth-century town". Bulletin of the History of Medicine. 76 (3): 495–527. doi:10.1353/bhm.2002.0150. PMID 12486915. S2CID 30791504.
Wexler NS (2012). "Huntington's disease: advocacy driving science". Annual Review of Medicine. 63: 1–22. doi:10.1146/annurev-med-050710-134457. PMID 22248319.
"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group". Cell. 72 (6): 971–983. March 1993. doi:10.1016/0092-8674(93)90585-E. hdl:2027.42/30901. PMID 8458085. S2CID 802885.
Bertram L, Tanzi RE (June 2005). "The genetic epidemiology of neurodegenerative disease". The Journal of Clinical Investigation. 115 (6): 1449–1457. doi:10.1172/JCI24761. PMC 1137006. PMID 15931380.
La Spada AR, Roling DB, Harding AE, Warner CL, Spiegel R, Hausmanowa-Petrusewicz I, et al. (December 1992). "Meiotic stability and genotype–phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy". Nature Genetics. 2 (4): 301–4. doi:10.1038/ng1292-301. PMID 1303283. S2CID 6603129.
Ross CA, Tabrizi SJ (January 2011). "Huntington's disease: from molecular pathogenesis to clinical treatment". The Lancet. Neurology. 10 (1): 83–98. doi:10.1016/S1474-4422(10)70245-3. PMID 21163446. S2CID 17488174.
Davenport CB (May 1915). "Huntington's Chorea in Relation to Heredity and Eugenics". Proceedings of the National Academy of Sciences of the United States of America. 1 (5): 283–5. Bibcode:1915PNAS....1..283D. doi:10.1073/pnas.1.5.283. PMC 1090803. PMID 16575999.
Rollin BE (2006). "The regulation of animal research and the emergence of animal ethics: a conceptual history" (PDF). Theoretical Medicine and Bioethics. 27 (4): 285–304. doi:10.1007/s11017-006-9007-8. PMID 16937023. S2CID 18620094. Archived from the original (PDF) on 8 October 2020. Retrieved 1 December 2019.
Doerflinger RM (February 2008). "The problem of deception in embryonic stem cell research". Cell Proliferation. 41 (Suppl 1): 65–70. doi:10.1111/j.1365-2184.2008.00492.x. PMC 6496399. PMID 18181947.
Binedell J, Soldan JR, Scourfield J, Harper PS (November 1996). "Huntington's disease predictive testing: the case for an assessment approach to requests from adolescents". Journal of Medical Genetics. 33 (11): 912–8. doi:10.1136/jmg.33.11.912. PMC 1050784. PMID 8950670.
Borry P, Goffin T, Nys H, Dierickx K (2008). "Predictive genetic testing in minors for adult-onset genetic diseases". The Mount Sinai Journal of Medicine, New York. 75 (3): 287–96. doi:10.1002/msj.20038. PMID 18704981.
Braude PR, De Wert GM, Evers-Kiebooms G, Pettigrew RA, Geraedts JP (December 1998). "Non-disclosure preimplantation genetic diagnosis for Huntington's disease: practical and ethical dilemmas". Prenatal Diagnosis. 18 (13): 1422–6. doi:10.1002/(SICI)1097-0223(199812)18:13<1422::AID-PD499>3.0.CO;2-R. PMID 9949442. S2CID 39977672.
Odling-Smee L (17 May 2007). "Biomedical philanthropy: The money tree". Nature. 447 (7142): 251. Bibcode:2007Natur.447..251.. doi:10.1038/447251a. S2CID 4357517.
Wild EJ, Tabrizi SJ (September 2014). "Targets for future clinical trials in Huntington's disease: what's in the pipeline?". Movement Disorders. 29 (11): 1434–45. doi:10.1002/mds.26007. PMC 4265300. PMID 25155142.
Check E (May 2007). "Biomedical philanthropy: love or money". Nature. 447 (7142): 252–3. Bibcode:2007Natur.447..252C. doi:10.1038/447252a. PMID 17507955. S2CID 4318384.
Munoz-Sanjuan I, Bates GP (February 2011). "The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease". The Journal of Clinical Investigation. 121 (2): 476–83. doi:10.1172/JCI45364. PMC 3026740. PMID 21285520.
McBride JL, Pitzer MR, Boudreau RL, Dufour B, Hobbs T, Ojeda SR, et al. (December 2011). "Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease". Molecular Therapy. 19 (12): 2152–62. doi:10.1038/mt.2011.219. PMC 3242667. PMID 22031240.
Kordasiewicz HB, Stanek LM, Wancewicz EV, Mazur C, McAlonis MM, Pytel KA, et al. (June 2012). "Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis". Neuron. 74 (6): 1031–44. doi:10.1016/j.neuron.2012.05.009. PMC 3383626. PMID 22726834.
Barnes DW, Whitley RJ (February 1987). "Antiviral therapy and pulmonary disease". Chest. 91 (2): 246–51. doi:10.1378/chest.91.2.246. PMID 3026739.
Wild EJ, Boggio R, Langbehn D, Robertson N, Haider S, Miller JR, et al. (May 2015). "Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients". The Journal of Clinical Investigation. 125 (5): 1979–86. doi:10.1172/jci80743. PMC 4463213. PMID 25844897.
Chase A (May 2015). "Huntington disease: cerebrospinal fluid and MRI biomarkers for prodromal HD". Nature Reviews Neurology. 11 (5): 245. doi:10.1038/nrneurol.2015.63. PMID 25896083. S2CID 38300571.
Keiser MS, Kordasiewicz HB, McBride JL (April 2016). "Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia". Human Molecular Genetics. 25 (R1): R53–64. doi:10.1093/hmg/ddv442. PMC 4802374. PMID 26503961.
Kwon D (6 April 2021). "Genetic therapies offer new hope against incurable brain diseases". Nature. 592 (7853): 180–183. Bibcode:2021Natur.592..180K. doi:10.1038/d41586-021-00870-x. PMID 33824521. S2CID 233173862.
Bhattacharyya A, Trotta CR, Narasimhan J, Wiedinger KJ, Li W, Effenberger KA, et al. (15 December 2021). "Small molecule splicing modifiers with systemic HTT-lowering activity". Nature Communications. 12 (1): 7299. Bibcode:2021NatCo..12.7299B. doi:10.1038/s41467-021-27157-z. ISSN 2041-1723. PMC 8674292. PMID 34911927.
Djajadikerta A, Keshri S, Pavel M, Prestil R, Ryan L, Rubinsztein DC (April 2020). "Autophagy Induction as a Therapeutic Strategy for Neurodegenerative Diseases". Journal of Molecular Biology. Autophagy in Neurodegenerative Diseases. 432 (8): 2799–2821. doi:10.1016/j.jmb.2019.12.035. PMID 31887286. S2CID 209518157. Archived from the original on 23 May 2022. Retrieved 20 June 2023.
Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, et al. (June 2004). "Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease". Nature Genetics. 36 (6): 585–595. doi:10.1038/ng1362. PMID 15146184. S2CID 7749825.
Holley SM, Kamdjou T, Reidling JC, Fury B, Coleal-Bergum D, Bauer G, et al. (April 2018). "Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings". CNS Neuroscience & Therapeutics. 24 (4). Wiley: 329–342. doi:10.1111/cns.12839. PMC 6489814. PMID 29512295.
Cundiff PE, Anderson SA (June 2011). "Impact of induced pluripotent stem cells on the study of central nervous system disease". Current Opinion in Genetics & Development. 21 (3): 354–61. doi:10.1016/j.gde.2011.01.008. PMC 3932563. PMID 21277194.
Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. (October 2017). "Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease". Cell. 171 (2): 273–285. doi:10.1016/j.cell.2017.09.021. PMC 5685180. PMID 28985560.

escholarship.org

Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, et al. (October 2001). "Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila". Nature. 413 (6857): 739–743. Bibcode:2001Natur.413..739S. doi:10.1038/35099568. PMID 11607033. S2CID 4419980. Archived from the original on 1 August 2020. Retrieved 28 June 2019.

euro-hd.net

"EHDN Physiotherapy Guidance Document" (PDF). European HD Network Physiotherapy Working Group. Archived from the original (PDF) on 4 March 2016. Retrieved 15 November 2015.

fda.gov

"FDA Approves First Drug for Treatment of Chorea in Huntington's Disease". U.S. Food and Drug Administration. 15 August 2008. Archived from the original on 21 August 2008. Retrieved 10 August 2008.
Center for Drug Evaluation Research (17 July 2019). "In Pursuit of Tardive Dyskinesia: The Breakthrough Designation and Approval of Valbenazine". FDA. Archived from the original on 3 December 2020. Retrieved 15 November 2020.

futuremedicine.com

Quin L, Busee M (February 2012). "Development of physiotherapy guidance and treatment-based classifications for people with Huntington's disease". Neurodegenerative Disease Management. 2 (1): 21–31. doi:10.2217/nmt.11.86. Archived from the original on 9 August 2020. Retrieved 10 May 2012.

genome.gov

"About Huntington's Disease". Genome.gov. Archived from the original on 9 January 2021. Retrieved 13 January 2021.
"Sex Linked". Genome.gov. Archived from the original on 14 April 2022. Retrieved 13 December 2022.

google.co.uk

scholar.google.co.uk

Vessie PR (1932). "On the transmission of Huntington's chorea for 300 years – the Bures family group". Nervous and Mental Disease. 76 (6): 553–573. doi:10.1097/00005053-193212000-00001. S2CID 147656032. Archived from the original on 28 August 2021. Retrieved 1 April 2009.

handle.net

hdl.handle.net

Wexler NS, Young AB, Tanzi RE, Travers H, Starosta-Rubinstein S, Penney JB, et al. (1987). "Homozygotes for Huntington's disease". Nature. 326 (6109): 194–197. Bibcode:1987Natur.326..194W. doi:10.1038/326194a0. hdl:2027.42/62543. PMID 2881213. S2CID 4312171.
Morsy S, Khalil SM, Doheim MF, Kamel MG, El-Basiony DS, Ahmed Hassan HI, et al. (August 2019). "Efficacy of ethyl-EPA as a treatment for Huntington disease: a systematic review and meta-analysis". Acta Neuropsychiatrica. 31 (4): 175–185. doi:10.1017/neu.2019.11. hdl:10069/39427. PMID 30890195. S2CID 84183892.
"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group". Cell. 72 (6): 971–983. March 1993. doi:10.1016/0092-8674(93)90585-E. hdl:2027.42/30901. PMID 8458085. S2CID 802885.

harvard.edu

ui.adsabs.harvard.edu

Wexler NS, Young AB, Tanzi RE, Travers H, Starosta-Rubinstein S, Penney JB, et al. (1987). "Homozygotes for Huntington's disease". Nature. 326 (6109): 194–197. Bibcode:1987Natur.326..194W. doi:10.1038/326194a0. hdl:2027.42/62543. PMID 2881213. S2CID 4312171.
Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, et al. (October 2001). "Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila". Nature. 413 (6857): 739–743. Bibcode:2001Natur.413..739S. doi:10.1038/35099568. PMID 11607033. S2CID 4419980. Archived from the original on 1 August 2020. Retrieved 28 June 2019.
Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, et al. (1983). "A polymorphic DNA marker genetically linked to Huntington's disease". Nature. 306 (5940): 234–8. Bibcode:1983Natur.306..234G. doi:10.1038/306234a0. PMID 6316146. S2CID 4320711.
Davenport CB (May 1915). "Huntington's Chorea in Relation to Heredity and Eugenics". Proceedings of the National Academy of Sciences of the United States of America. 1 (5): 283–5. Bibcode:1915PNAS....1..283D. doi:10.1073/pnas.1.5.283. PMC 1090803. PMID 16575999.
Odling-Smee L (17 May 2007). "Biomedical philanthropy: The money tree". Nature. 447 (7142): 251. Bibcode:2007Natur.447..251.. doi:10.1038/447251a. S2CID 4357517.
Check E (May 2007). "Biomedical philanthropy: love or money". Nature. 447 (7142): 252–3. Bibcode:2007Natur.447..252C. doi:10.1038/447252a. PMID 17507955. S2CID 4318384.
Kwon D (6 April 2021). "Genetic therapies offer new hope against incurable brain diseases". Nature. 592 (7853): 180–183. Bibcode:2021Natur.592..180K. doi:10.1038/d41586-021-00870-x. PMID 33824521. S2CID 233173862.
Bhattacharyya A, Trotta CR, Narasimhan J, Wiedinger KJ, Li W, Effenberger KA, et al. (15 December 2021). "Small molecule splicing modifiers with systemic HTT-lowering activity". Nature Communications. 12 (1): 7299. Bibcode:2021NatCo..12.7299B. doi:10.1038/s41467-021-27157-z. ISSN 2041-1723. PMC 8674292. PMID 34911927.

hathitrust.org

babel.hathitrust.org

Huntington G (1872). "On Chorea". Medical and Surgical Reporter of Philadelphia. 26 (15): 317–321. ISBN 978-90-6186-011-2. Archived from the original on 21 April 2022. Retrieved 21 April 2022.
Dunglison R (1842). The Practice of Medicine ... Vol. 2. Philadelphia, Pennsylvania, USA: Lea & Blanchard. pp. 312–313. Archived from the original on 20 April 2022. Retrieved 20 April 2022.
Osler W (1908). "Historical notes on hereditary chorea". Neurographs. 1 (2): 113–116. Archived from the original on 21 April 2022. Retrieved 21 April 2022. See p. 115.
- See also: Osler W (February 1893). "Remarks on the varieties of chronic chorea, and a report upon two families of the hereditary form, with one autopsy". The Journal of Nervous and Mental Disease. 20 (2): 97–111. Archived from the original on 21 April 2022. Retrieved 21 April 2022.
- Davenport CB, Muncey EB (1916). "Huntington's chorea in relation to heredity and eugenics". American Journal of Insanity. 73 (2): 195–222. doi:10.1176/ajp.73.2.195.

hda.org.uk

"What is HD?". Huntington's disease association. Archived from the original on 13 December 2011. Retrieved 18 December 2011.

hdac.org

"Booklet by the Huntington Society of Canada" (PDF). Caregiver's Handbook for Advanced-Stage Huntington Disease. HD Society of Canada. 11 April 2007. Archived from the original (PDF) on 25 June 2008. Retrieved 10 August 2008.

hdbuzz.net

en.hdbuzz.net

Harding R (26 April 2021). Fox L (ed.). "Huntington's disease clinical trial round up". HDBuzz. Archived from the original on 5 May 2021. Retrieved 5 May 2021.

hdfoundation.org

"History of the HDF". Hereditary Disease Foundation. Archived from the original on 19 November 2015. Retrieved 18 November 2015.
"The Venezuela Huntington's disease project". Hereditary Disease Foundation website. Hereditary Disease Foundation. 2008. Archived from the original on 10 August 2015. Retrieved 8 September 2008.

hdsa.org

"History and Genetics of Huntington's Disease | Huntington's Disease Society of America". March 2019. Archived from the original on 1 December 2020. Retrieved 14 December 2020.

huntington-assoc.com

"The International Huntington Association". International Huntington Association. 2013. Archived from the original on 18 April 2009. Retrieved 3 April 2009.

huntington-study-group.org

"Completed Clinical Trials". Huntington Study Group. Archived from the original on 28 June 2012. Retrieved 4 February 2012.

huntingtonstudygroup.org

"Unified Huntington's Disease Rating Scale (UHDRS)". UHDRS and Database. HSG. 1 February 2009. Archived from the original on 11 August 2015. Retrieved 14 April 2009.

jefferson.edu

jdc.jefferson.edu

Gorman CR (1846). On a Form of Chorea, Vulgarly called Magrums (Doctor of Medicine thesis). Philadelphia: Jefferson Medical College.
- "Catalogue of Jefferson Medical College of Philadelphia: Session of 1846-7". p. 14. Archived from the original on 26 June 2022.

kuleuven.be

lirias.kuleuven.be

Borry P, Goffin T, Nys H, Dierickx K (2008). "Predictive genetic testing in minors for adult-onset genetic diseases". The Mount Sinai Journal of Medicine, New York. 75 (3): 287–96. doi:10.1002/msj.20038. PMID 18704981.

mayoclinic.org

"Huntington's disease - Symptoms and causes". Mayo Clinic. Archived from the original on 5 March 2018. Retrieved 13 December 2022.

medscape.com

emedicine.medscape.com

Sharon I, Sharon R, Wilkens JP, Ersan T (2010). "Huntington Disease Dementia". emedicine, WebMD. Medscape. Archived from the original on 5 March 2010. Retrieved 16 May 2010.

msu.ru

protein.bio.msu.ru

Illarioshkin SN, Klyushnikov SA, Vigont VA, Seliverstov YA, Kaznacheyeva EV (September 2018). "Molecular Pathogenesis in Huntington's Disease". Biochemistry. Biokhimiia. 83 (9): 1030–1039. doi:10.1134/S0006297918090043. PMID 30472941. S2CID 26471825. Archived from the original on 13 November 2020. Retrieved 8 November 2020 – via protein.bio.msu.ru.

nhs.uk

"Huntington's disease - Treatment and support". National Health Service UK. 23 October 2017. Archived from the original on 6 May 2023. Retrieved 6 May 2023.

nhsinform.scot

"Huntington's disease". www.nhsinform.scot. Archived from the original on 12 July 2020. Retrieved 12 July 2020.

nih.gov

pubmed.ncbi.nlm.nih.gov

Dayalu P, Albin RL (February 2015). "Huntington disease: pathogenesis and treatment". Neurologic Clinics. 33 (1): 101–114. doi:10.1016/j.ncl.2014.09.003. PMID 25432725.
Caron NS, Wright GE, Hayden MR (2020). Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Stephens K, Amemiya A (eds.). "Huntington Disease". GeneReviews. PMID 20301482.
Frank S (January 2014). "Treatment of Huntington's disease". Neurotherapeutics. 11 (1): 153–160. doi:10.1007/s13311-013-0244-z. PMC 3899480. PMID 24366610.
Durr A, Gargiulo M, Feingold J (November 2012). "The presymptomatic phase of Huntington disease". Revue Neurologique. 168 (11): 806–808. doi:10.1016/j.neurol.2012.07.003. PMID 22902173.
Illarioshkin SN, Klyushnikov SA, Vigont VA, Seliverstov YA, Kaznacheyeva EV (September 2018). "Molecular Pathogenesis in Huntington's Disease". Biochemistry. Biokhimiia. 83 (9): 1030–1039. doi:10.1134/S0006297918090043. PMID 30472941. S2CID 26471825. Archived from the original on 13 November 2020. Retrieved 8 November 2020 – via protein.bio.msu.ru.
Sudhakar V, Richardson RM (January 2019). "Gene Therapy for Neurodegenerative Diseases". Neurotherapeutics. 16 (1): 166–175. doi:10.1007/s13311-018-00694-0. PMC 6361055. PMID 30542906.
Saudou F, Humbert S (March 2016). "The Biology of Huntingtin". Neuron. 89 (5): 910–926. doi:10.1016/j.neuron.2016.02.003. PMID 26938440. S2CID 8272667.
Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, et al. (April 2015). "Huntington disease". Nature Reviews. Disease Primers. 1: 15005. doi:10.1038/nrdp.2015.5. PMID 27188817. S2CID 25759303.
Vale TC, Cardoso F (2015). "Chorea: A Journey through History". Tremor and Other Hyperkinetic Movements. 5. doi:10.7916/D8WM1C98 (inactive 1 November 2024). PMC 4454991. PMID 26056609.{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)
Jensen RN, Bolwig T, Sørensen SA (March 2018). "[Psychiatric symptoms in patients with Huntington's disease]". Ugeskrift for Laeger (in Danish). 180 (13). PMID 29587954.
Caron NS, Wright GE, Hayden MR (June 2020). "Huntington Disease". Genereviews Bookshelf. University of Washington. PMID 20301482. Archived from the original on 10 February 2009. Retrieved 22 November 2020.
Walker FO (January 2007). "Huntington's disease". Lancet. 369 (9557): 218–228. doi:10.1016/S0140-6736(07)60111-1. PMID 17240289. S2CID 46151626.
Montoya A, Price BH, Menear M, Lepage M (January 2006). "Brain imaging and cognitive dysfunctions in Huntington's disease" (PDF). Journal of Psychiatry & Neuroscience. 31 (1): 21–29. PMC 1325063. PMID 16496032. Archived from the original (PDF) on 23 March 2016. Retrieved 17 September 2008.
Dickey AS, La Spada AR (April 2018). "Therapy development in Huntington disease: From current strategies to emerging opportunities". American Journal of Medical Genetics. Part A. 176 (4): 842–861. doi:10.1002/ajmg.a.38494. PMC 5975251. PMID 29218782.
Aziz NA, van der Marck MA, Pijl H, Olde Rikkert MG, Bloem BR, Roos RA (December 2008). "Weight loss in neurodegenerative disorders". Journal of Neurology. 255 (12): 1872–1880. doi:10.1007/s00415-009-0062-8. PMID 19165531. S2CID 26109381.
van Duijn E, Kingma EM, van der Mast RC (2007). "Psychopathology in verified Huntington's disease gene carriers". The Journal of Neuropsychiatry and Clinical Neurosciences. 19 (4): 441–448. doi:10.1176/appi.neuropsych.19.4.441. PMID 18070848.
van der Burg JM, Björkqvist M, Brundin P (August 2009). "Beyond the brain: widespread pathology in Huntington's disease". The Lancet. Neurology. 8 (8): 765–774. doi:10.1016/S1474-4422(09)70178-4. PMID 19608102. S2CID 14419437.
Katsuno M, Banno H, Suzuki K, Takeuchi Y, Kawashima M, Tanaka F, et al. (May 2008). "Molecular genetics and biomarkers of polyglutamine diseases". Current Molecular Medicine. 8 (3): 221–234. doi:10.2174/156652408784221298. PMID 18473821.
Squitieri F, Frati L, Ciarmiello A, Lastoria S, Quarrell O (February 2006). "Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease?". Mechanisms of Ageing and Development. 127 (2): 208–212. doi:10.1016/j.mad.2005.09.012. PMID 16274727. S2CID 20523093.
Nance MA, Myers RH (2001). "Juvenile onset Huntington's disease--clinical and research perspectives". Mental Retardation and Developmental Disabilities Research Reviews. 7 (3): 153–157. doi:10.1002/mrdd.1022. PMID 11553930.
Ridley RM, Frith CD, Crow TJ, Conneally PM (September 1988). "Anticipation in Huntington's disease is inherited through the male line but may originate in the female". Journal of Medical Genetics. 25 (9): 589–595. doi:10.1136/jmg.25.9.589. PMC 1051535. PMID 2972838.
Semaka A, Creighton S, Warby S, Hayden MR (October 2006). "Predictive testing for Huntington disease: interpretation and significance of intermediate alleles". Clinical Genetics. 70 (4): 283–294. doi:10.1111/j.1399-0004.2006.00668.x. PMID 16965319. S2CID 26007984.
Wexler NS, Young AB, Tanzi RE, Travers H, Starosta-Rubinstein S, Penney JB, et al. (1987). "Homozygotes for Huntington's disease". Nature. 326 (6109): 194–197. Bibcode:1987Natur.326..194W. doi:10.1038/326194a0. hdl:2027.42/62543. PMID 2881213. S2CID 4312171.
Squitieri F, Gellera C, Cannella M, Mariotti C, Cislaghi G, Rubinsztein DC, et al. (April 2003). "Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course". Brain. 126 (Pt 4): 946–955. doi:10.1093/brain/awg077. PMID 12615650.
Goehler H, Lalowski M, Stelzl U, Waelter S, Stroedicke M, Worm U, et al. (September 2004). "A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease". Molecular Cell. 15 (6): 853–865. doi:10.1016/j.molcel.2004.09.016. PMID 15383276.
Glajch KE, Sadri-Vakili G (2015). "Epigenetic Mechanisms Involved in Huntington's Disease Pathogenesis". Journal of Huntington's Disease. 4 (1): 1–15. doi:10.3233/JHD-159001. PMID 25813218.
Liu Z, Zhou T, Ziegler AC, Dimitrion P, Zuo L (2017). "Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications". Oxidative Medicine and Cellular Longevity. 2017: 2525967. doi:10.1155/2017/2525967. PMC 5529664. PMID 28785371.
Cattaneo E, Zuccato C, Tartari M (December 2005). "Normal huntingtin function: an alternative approach to Huntington's disease". Nature Reviews. Neuroscience. 6 (12): 919–930. doi:10.1038/nrn1806. PMID 16288298. S2CID 10119487.
Rubinsztein DC, Carmichael J (August 2003). "Huntington's disease: molecular basis of neurodegeneration". Expert Reviews in Molecular Medicine. 5 (20): 1–21. doi:10.1017/S1462399403006549. PMID 14585171. S2CID 28435830.
Bloch M, Hayden MR (January 1990). "Opinion: predictive testing for Huntington disease in childhood: challenges and implications". American Journal of Human Genetics. 46 (1): 1–4. PMC 1683548. PMID 2136787.
Matlahov I, van der Wel PC (December 2019). "Conformational studies of pathogenic expanded polyglutamine protein deposits from Huntington's disease". Experimental Biology and Medicine. 244 (17): 1584–1595. doi:10.1177/1535370219856620. PMC 6920524. PMID 31203656. S2CID 189944779.
Sadri-Vakili G, Cha JH (June 2006). "Mechanisms of disease: Histone modifications in Huntington's disease". Nature Clinical Practice. Neurology. 2 (6): 330–338. doi:10.1038/ncpneuro0199. PMID 16932577. S2CID 12474262.
Kumar A, Ratan RR (October 2016). "Oxidative Stress and Huntington's Disease: The Good, The Bad, and The Ugly". Journal of Huntington's Disease. 5 (3): 217–237. doi:10.3233/JHD-160205. PMC 5310831. PMID 27662334.
Nopoulos PC (March 2016). "Huntington disease: a single-gene degenerative disorder of the striatum". Dialogues in Clinical Neuroscience. 18 (1): 91–98. doi:10.31887/DCNS.2016.18.1/pnopoulos. PMC 4826775. PMID 27069383.
McColgan P, Tabrizi SJ (January 2018). "Huntington's disease: a clinical review". European Journal of Neurology. 25 (1): 24–34. doi:10.1111/ene.13413. PMID 28817209.
Lobsiger CS, Cleveland DW (November 2007). "Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease". Nature Neuroscience. 10 (11): 1355–1360. doi:10.1038/nn1988. PMC 3110080. PMID 17965655.
Crossman AR (May 2000). "Functional anatomy of movement disorders". Journal of Anatomy. 196 (Pt 4): 519–525. doi:10.1046/j.1469-7580.2000.19640519.x. PMC 1468094. PMID 10923984.
Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, et al. (October 2001). "Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila". Nature. 413 (6857): 739–743. Bibcode:2001Natur.413..739S. doi:10.1038/35099568. PMID 11607033. S2CID 4419980. Archived from the original on 1 August 2020. Retrieved 28 June 2019.
Petruska J, Hartenstine MJ, Goodman MF (February 1998). "Analysis of strand slippage in DNA polymerase expansions of CAG/CTG triplet repeats associated with neurodegenerative disease". The Journal of Biological Chemistry. 273 (9): 5204–5210. doi:10.1074/jbc.273.9.5204. PMID 9478975.
Rao AK, Muratori L, Louis ED, Moskowitz CB, Marder KS (April 2009). "Clinical measurement of mobility and balance impairments in Huntington's disease: validity and responsiveness". Gait & Posture. 29 (3): 433–436. doi:10.1016/j.gaitpost.2008.11.002. PMID 19111470.
Myers RH (April 2004). "Huntington's disease genetics". NeuroRx. 1 (2): 255–262. doi:10.1602/neurorx.1.2.255. PMC 534940. PMID 15717026.
de Die-Smulders CE, de Wert GM, Liebaers I, Tibben A, Evers-Kiebooms G (May 2013). "Reproductive options for prospective parents in families with Huntington's disease: clinical, psychological and ethical reflections". Human Reproduction Update. 19 (3): 304–315. doi:10.1093/humupd/dms058. PMID 23377865. de Die-Smulders CE, de Wert GM, Liebaers I, Tibben A, Evers-Kiebooms G (2013). "Reproductive options for prospective parents in families with Huntington's disease: clinical, psychological and ethical reflections". Human Reproduction Update. 19 (3): 304–315. doi:10.1093/humupd/dms058. PMID 23377865.
Baig SS, Strong M, Rosser E, Taverner NV, Glew R, Miedzybrodzka Z, et al. (October 2016). "22 Years of predictive testing for Huntington's disease: the experience of the UK Huntington's Prediction Consortium". European Journal of Human Genetics. 24 (10): 1396–1402. doi:10.1038/ejhg.2016.36. PMC 5027682. PMID 27165004.
Forrest Keenan K, Simpson SA, Miedzybrodzka Z, Alexander DA, Semper J (June 2013). "How do partners find out about the risk of Huntington's disease in couple relationships?". Journal of Genetic Counseling. 22 (3): 336–344. doi:10.1007/s10897-012-9562-2. PMID 23297124. S2CID 15447709.
Erwin C, Williams JK, Juhl AR, Mengeling M, Mills JA, Bombard Y, et al. (July 2010). "Perception, experience, and response to genetic discrimination in Huntington disease: the international RESPOND-HD study". American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics. 153B (5): 1081–1093. doi:10.1002/ajmg.b.31079. PMC 3593716. PMID 20468061.
Burson CM, Markey KR (September 2001). "Genetic counseling issues in predictive genetic testing for familial adult-onset neurologic diseases". Seminars in Pediatric Neurology. 8 (3): 177–186. doi:10.1053/spen.2001.26451. PMID 11575847.
Smith JA, Michie S, Stephenson M, Quarrell O (March 2002). "Risk Perception and Decision-making Processes in Candidates for Genetic Testing for Huntington's Disease: An Interpretative Phenomenological Analysis". Journal of Health Psychology. 7 (2): 131–144. doi:10.1177/1359105302007002398. PMID 22114233. S2CID 40182214.
Hayden MR (March 2003). "Predictive testing for Huntington's disease: a universal model?". The Lancet. Neurology. 2 (3): 141–142. doi:10.1016/S1474-4422(03)00317-X. PMID 12849232. S2CID 39581496.
"Guidelines for the molecular genetics predictive test in Huntington's disease. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea". Neurology. 44 (8): 1533–1536. August 1994. doi:10.1212/WNL.44.8.1533. PMID 8058167. S2CID 28018134.
Losekoot M, van Belzen MJ, Seneca S, Bauer P, Stenhouse SA, Barton DE (May 2013). "EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease". European Journal of Human Genetics. 21 (5): 480–486. doi:10.1038/ejhg.2012.200. PMC 3641377. PMID 22990145.
Schulman JD, Black SH, Handyside A, Nance WE (February 1996). "Preimplantation genetic testing for Huntington disease and certain other dominantly inherited disorders". Clinical Genetics. 49 (2): 57–58. doi:10.1111/j.1399-0004.1996.tb04327.x. PMID 8740912. S2CID 45703511.
Stern HJ, Harton GL, Sisson ME, Jones SL, Fallon LA, Thorsell LP, et al. (June 2002). "Non-disclosing preimplantation genetic diagnosis for Huntington disease". Prenatal Diagnosis. 22 (6): 503–507. doi:10.1002/pd.359. PMID 12116316. S2CID 33967835.
Kuliev A, Verlinsky Y (April 2005). "Preimplantation diagnosis: a realistic option for assisted reproduction and genetic practice". Current Opinion in Obstetrics & Gynecology. 17 (2): 179–183. doi:10.1097/01.gco.0000162189.76349.c5. PMID 15758612. S2CID 9382420.
Schneider SA, Walker RH, Bhatia KP (September 2007). "The Huntington's disease-like syndromes: what to consider in patients with a negative Huntington's disease gene test". Nature Clinical Practice. Neurology. 3 (9): 517–525. doi:10.1038/ncpneuro0606. PMID 17805246. S2CID 9052603.
Frank S, Jankovic J (March 2010). "Advances in the pharmacological management of Huntington's disease". Drugs. 70 (5): 561–571. doi:10.2165/11534430-000000000-00000. PMID 20329804. S2CID 42386743. Archived from the original on 8 October 2011.
Bonelli RM, Wenning GK, Kapfhammer HP (March 2004). "Huntington's disease: present treatments and future therapeutic modalities". International Clinical Psychopharmacology. 19 (2): 51–62. doi:10.1097/00004850-200403000-00001. PMID 15076012. S2CID 1956458.
Panagiotakis PH, DiSario JA, Hilden K, Ogara M, Fang JC (2008). "DPEJ tube placement prevents aspiration pneumonia in high-risk patients". Nutrition in Clinical Practice. 23 (2): 172–175. doi:10.1177/0884533608314537. PMID 18390785.
Khalil H, Quinn L, van Deursen R, Martin R, Rosser A, Busse M (January 2012). "Adherence to use of a home-based exercise DVD in people with Huntington disease: participants' perspectives". Physical Therapy. 92 (1): 69–82. doi:10.2522/ptj.20100438. PMID 21960468.
Travers E, Jones K, Nichol J (March 2007). "Palliative care provision in Huntington's disease". International Journal of Palliative Nursing. 13 (3): 125–130. doi:10.12968/ijpn.2007.13.3.23274. PMID 17505405.
Coppen EM, Roos RA (January 2017). "Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease". Drugs. 77 (1): 29–46. doi:10.1007/s40265-016-0670-4. PMC 5216093. PMID 27988871.
Morsy S, Khalil SM, Doheim MF, Kamel MG, El-Basiony DS, Ahmed Hassan HI, et al. (August 2019). "Efficacy of ethyl-EPA as a treatment for Huntington disease: a systematic review and meta-analysis". Acta Neuropsychiatrica. 31 (4): 175–185. doi:10.1017/neu.2019.11. hdl:10069/39427. PMID 30890195. S2CID 84183892.
Llamas E, Koyuncu S, Lee HJ, Wehrmann M, Gutierrez-Garcia R, Dunken N, et al. (November 2023). "In planta expression of human polyQ-expanded huntingtin fragment reveals mechanisms to prevent disease-related protein aggregation". Nature Aging. 3 (11): 1345–1357. doi:10.1038/s43587-023-00502-1. PMC 10645592. PMID 37783816.
A'Campo LE, Spliethoff-Kamminga NG, Roos RA (2012). "The Patient Education Program for Huntington's Disease (PEP-HD)". J Huntingtons Dis. 1 (1): 47–56. doi:10.3233/JHD-2012-120002. PMID 25063190.
Harper PS (June 1999). "Huntington's disease: a clinical, genetic and molecular model for polyglutamine repeat disorders". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 354 (1386): 957–61. doi:10.1098/rstb.1999.0446. PMC 1692597. PMID 10434293.
Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, et al. (August 1993). "The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease". Nature Genetics. 4 (4): 398–403. doi:10.1038/ng0893-398. PMID 8401589. S2CID 20645822.
Walker FO (January 2007). "Huntington's disease". Lancet. 369 (9557): 218–28. doi:10.1016/S0140-6736(07)60111-1. PMID 17240289. S2CID 46151626.
Di Maio L, Squitieri F, Napolitano G, Campanella G, Trofatter JA, Conneally PM (April 1993). "Suicide risk in Huntington's disease". Journal of Medical Genetics. 30 (4): 293–5. doi:10.1136/jmg.30.4.293. PMC 1016335. PMID 8487273.
Evans SJ, Douglas I, Rawlins MD, Wexler NS, Tabrizi SJ, Smeeth L (October 2013). "Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records". Journal of Neurology, Neurosurgery, and Psychiatry. 84 (10): 1156–60. doi:10.1136/jnnp-2012-304636. PMC 3786631. PMID 23482661.
Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, et al. (1983). "A polymorphic DNA marker genetically linked to Huntington's disease". Nature. 306 (5940): 234–8. Bibcode:1983Natur.306..234G. doi:10.1038/306234a0. PMID 6316146. S2CID 4320711.
Squitieri F, Andrew SE, Goldberg YP, Kremer B, Spence N, Zeisler J, et al. (December 1994). "DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence". Human Molecular Genetics. 3 (12): 2103–14. doi:10.1093/hmg/3.12.2103. PMID 7881406.
Sveinsson O, Halldórsson S, Olafsson E (July 2012). "An unusually low prevalence of Huntington's disease in Iceland". European Neurology. 68 (1): 48–51. doi:10.1159/000337680. PMID 22722209. S2CID 207551998.
Sipilä JO, Hietala M, Siitonen A, Päivärinta M, Majamaa K (January 2015). "Epidemiology of Huntington's disease in Finland". Parkinsonism & Related Disorders. 21 (1): 46–9. doi:10.1016/j.parkreldis.2014.10.025. PMID 25466405.
Almqvist EW, Elterman DS, MacLeod PM, Hayden MR (September 2001). "High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia". Clinical Genetics. 60 (3): 198–205. doi:10.1034/j.1399-0004.2001.600305.x. PMID 11595021. S2CID 19786394.
Lanska DJ (April 2000). "George Huntington (1850–1916) and hereditary chorea". Journal of the History of the Neurosciences. 9 (1): 76–89. doi:10.1076/0964-704X(200004)9:1;1-2;FT076. PMID 11232352. S2CID 22659368.
Brody IA, Wilkins RH (September 1967). "Huntington's chorea". Archives of Neurology. 17 (3): 331. doi:10.1001/archneur.1967.00470270109013. PMID 4228262.
Wexler AR (2002). "Chorea and community in a nineteenth-century town". Bulletin of the History of Medicine. 76 (3): 495–527. doi:10.1353/bhm.2002.0150. PMID 12486915. S2CID 30791504.
Conneally PM (May 1984). "Huntington disease: genetics and epidemiology". American Journal of Human Genetics. 36 (3): 506–26. PMC 1684448. PMID 6233902.
Wexler NS (2012). "Huntington's disease: advocacy driving science". Annual Review of Medicine. 63: 1–22. doi:10.1146/annurev-med-050710-134457. PMID 22248319.
"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group". Cell. 72 (6): 971–983. March 1993. doi:10.1016/0092-8674(93)90585-E. hdl:2027.42/30901. PMID 8458085. S2CID 802885.
Bertram L, Tanzi RE (June 2005). "The genetic epidemiology of neurodegenerative disease". The Journal of Clinical Investigation. 115 (6): 1449–1457. doi:10.1172/JCI24761. PMC 1137006. PMID 15931380.
La Spada AR, Roling DB, Harding AE, Warner CL, Spiegel R, Hausmanowa-Petrusewicz I, et al. (December 1992). "Meiotic stability and genotype–phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy". Nature Genetics. 2 (4): 301–4. doi:10.1038/ng1292-301. PMID 1303283. S2CID 6603129.
Ross CA, Tabrizi SJ (January 2011). "Huntington's disease: from molecular pathogenesis to clinical treatment". The Lancet. Neurology. 10 (1): 83–98. doi:10.1016/S1474-4422(10)70245-3. PMID 21163446. S2CID 17488174.
Davenport CB (May 1915). "Huntington's Chorea in Relation to Heredity and Eugenics". Proceedings of the National Academy of Sciences of the United States of America. 1 (5): 283–5. Bibcode:1915PNAS....1..283D. doi:10.1073/pnas.1.5.283. PMC 1090803. PMID 16575999.
Rollin BE (2006). "The regulation of animal research and the emergence of animal ethics: a conceptual history" (PDF). Theoretical Medicine and Bioethics. 27 (4): 285–304. doi:10.1007/s11017-006-9007-8. PMID 16937023. S2CID 18620094. Archived from the original (PDF) on 8 October 2020. Retrieved 1 December 2019.
Doerflinger RM (February 2008). "The problem of deception in embryonic stem cell research". Cell Proliferation. 41 (Suppl 1): 65–70. doi:10.1111/j.1365-2184.2008.00492.x. PMC 6496399. PMID 18181947.
Chapman MA (July 1990). "Predictive testing for adult-onset genetic disease: ethical and legal implications of the use of linkage analysis for Huntington disease". American Journal of Human Genetics. 47 (1): 1–3. PMC 1683745. PMID 2140926.
Huggins M, Bloch M, Kanani S, Quarrell OW, Theilman J, Hedrick A, et al. (July 1990). "Ethical and legal dilemmas arising during predictive testing for adult-onset disease: the experience of Huntington disease". American Journal of Human Genetics. 47 (1): 4–12. PMC 1683755. PMID 1971997.
Binedell J, Soldan JR, Scourfield J, Harper PS (November 1996). "Huntington's disease predictive testing: the case for an assessment approach to requests from adolescents". Journal of Medical Genetics. 33 (11): 912–8. doi:10.1136/jmg.33.11.912. PMC 1050784. PMID 8950670.
Borry P, Goffin T, Nys H, Dierickx K (2008). "Predictive genetic testing in minors for adult-onset genetic diseases". The Mount Sinai Journal of Medicine, New York. 75 (3): 287–96. doi:10.1002/msj.20038. PMID 18704981.
Braude PR, De Wert GM, Evers-Kiebooms G, Pettigrew RA, Geraedts JP (December 1998). "Non-disclosure preimplantation genetic diagnosis for Huntington's disease: practical and ethical dilemmas". Prenatal Diagnosis. 18 (13): 1422–6. doi:10.1002/(SICI)1097-0223(199812)18:13<1422::AID-PD499>3.0.CO;2-R. PMID 9949442. S2CID 39977672.
Wild EJ, Tabrizi SJ (September 2014). "Targets for future clinical trials in Huntington's disease: what's in the pipeline?". Movement Disorders. 29 (11): 1434–45. doi:10.1002/mds.26007. PMC 4265300. PMID 25155142.
Check E (May 2007). "Biomedical philanthropy: love or money". Nature. 447 (7142): 252–3. Bibcode:2007Natur.447..252C. doi:10.1038/447252a. PMID 17507955. S2CID 4318384.
Munoz-Sanjuan I, Bates GP (February 2011). "The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease". The Journal of Clinical Investigation. 121 (2): 476–83. doi:10.1172/JCI45364. PMC 3026740. PMID 21285520.
McBride JL, Pitzer MR, Boudreau RL, Dufour B, Hobbs T, Ojeda SR, et al. (December 2011). "Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease". Molecular Therapy. 19 (12): 2152–62. doi:10.1038/mt.2011.219. PMC 3242667. PMID 22031240.
Kordasiewicz HB, Stanek LM, Wancewicz EV, Mazur C, McAlonis MM, Pytel KA, et al. (June 2012). "Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis". Neuron. 74 (6): 1031–44. doi:10.1016/j.neuron.2012.05.009. PMC 3383626. PMID 22726834.
Barnes DW, Whitley RJ (February 1987). "Antiviral therapy and pulmonary disease". Chest. 91 (2): 246–51. doi:10.1378/chest.91.2.246. PMID 3026739.
Wild EJ, Boggio R, Langbehn D, Robertson N, Haider S, Miller JR, et al. (May 2015). "Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients". The Journal of Clinical Investigation. 125 (5): 1979–86. doi:10.1172/jci80743. PMC 4463213. PMID 25844897.
Chase A (May 2015). "Huntington disease: cerebrospinal fluid and MRI biomarkers for prodromal HD". Nature Reviews Neurology. 11 (5): 245. doi:10.1038/nrneurol.2015.63. PMID 25896083. S2CID 38300571.
Keiser MS, Kordasiewicz HB, McBride JL (April 2016). "Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia". Human Molecular Genetics. 25 (R1): R53–64. doi:10.1093/hmg/ddv442. PMC 4802374. PMID 26503961.
Kwon D (6 April 2021). "Genetic therapies offer new hope against incurable brain diseases". Nature. 592 (7853): 180–183. Bibcode:2021Natur.592..180K. doi:10.1038/d41586-021-00870-x. PMID 33824521. S2CID 233173862.
Bhattacharyya A, Trotta CR, Narasimhan J, Wiedinger KJ, Li W, Effenberger KA, et al. (15 December 2021). "Small molecule splicing modifiers with systemic HTT-lowering activity". Nature Communications. 12 (1): 7299. Bibcode:2021NatCo..12.7299B. doi:10.1038/s41467-021-27157-z. ISSN 2041-1723. PMC 8674292. PMID 34911927.
Djajadikerta A, Keshri S, Pavel M, Prestil R, Ryan L, Rubinsztein DC (April 2020). "Autophagy Induction as a Therapeutic Strategy for Neurodegenerative Diseases". Journal of Molecular Biology. Autophagy in Neurodegenerative Diseases. 432 (8): 2799–2821. doi:10.1016/j.jmb.2019.12.035. PMID 31887286. S2CID 209518157. Archived from the original on 23 May 2022. Retrieved 20 June 2023.
Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, et al. (June 2004). "Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease". Nature Genetics. 36 (6): 585–595. doi:10.1038/ng1362. PMID 15146184. S2CID 7749825.
Holley SM, Kamdjou T, Reidling JC, Fury B, Coleal-Bergum D, Bauer G, et al. (April 2018). "Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings". CNS Neuroscience & Therapeutics. 24 (4). Wiley: 329–342. doi:10.1111/cns.12839. PMC 6489814. PMID 29512295.
Cundiff PE, Anderson SA (June 2011). "Impact of induced pluripotent stem cells on the study of central nervous system disease". Current Opinion in Genetics & Development. 21 (3): 354–61. doi:10.1016/j.gde.2011.01.008. PMC 3932563. PMID 21277194.
Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. (October 2017). "Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease". Cell. 171 (2): 273–285. doi:10.1016/j.cell.2017.09.021. PMC 5685180. PMID 28985560.

ncbi.nlm.nih.gov

Frank S (January 2014). "Treatment of Huntington's disease". Neurotherapeutics. 11 (1): 153–160. doi:10.1007/s13311-013-0244-z. PMC 3899480. PMID 24366610.
Sudhakar V, Richardson RM (January 2019). "Gene Therapy for Neurodegenerative Diseases". Neurotherapeutics. 16 (1): 166–175. doi:10.1007/s13311-018-00694-0. PMC 6361055. PMID 30542906.
Vale TC, Cardoso F (2015). "Chorea: A Journey through History". Tremor and Other Hyperkinetic Movements. 5. doi:10.7916/D8WM1C98 (inactive 1 November 2024). PMC 4454991. PMID 26056609.{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)
Caron NS, Wright GE, Hayden MR (June 2020). "Huntington Disease". Genereviews Bookshelf. University of Washington. PMID 20301482. Archived from the original on 10 February 2009. Retrieved 22 November 2020.
Montoya A, Price BH, Menear M, Lepage M (January 2006). "Brain imaging and cognitive dysfunctions in Huntington's disease" (PDF). Journal of Psychiatry & Neuroscience. 31 (1): 21–29. PMC 1325063. PMID 16496032. Archived from the original (PDF) on 23 March 2016. Retrieved 17 September 2008.
Dickey AS, La Spada AR (April 2018). "Therapy development in Huntington disease: From current strategies to emerging opportunities". American Journal of Medical Genetics. Part A. 176 (4): 842–861. doi:10.1002/ajmg.a.38494. PMC 5975251. PMID 29218782.
Ridley RM, Frith CD, Crow TJ, Conneally PM (September 1988). "Anticipation in Huntington's disease is inherited through the male line but may originate in the female". Journal of Medical Genetics. 25 (9): 589–595. doi:10.1136/jmg.25.9.589. PMC 1051535. PMID 2972838.
Liu Z, Zhou T, Ziegler AC, Dimitrion P, Zuo L (2017). "Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications". Oxidative Medicine and Cellular Longevity. 2017: 2525967. doi:10.1155/2017/2525967. PMC 5529664. PMID 28785371.
Bloch M, Hayden MR (January 1990). "Opinion: predictive testing for Huntington disease in childhood: challenges and implications". American Journal of Human Genetics. 46 (1): 1–4. PMC 1683548. PMID 2136787.
Matlahov I, van der Wel PC (December 2019). "Conformational studies of pathogenic expanded polyglutamine protein deposits from Huntington's disease". Experimental Biology and Medicine. 244 (17): 1584–1595. doi:10.1177/1535370219856620. PMC 6920524. PMID 31203656. S2CID 189944779.
Kumar A, Ratan RR (October 2016). "Oxidative Stress and Huntington's Disease: The Good, The Bad, and The Ugly". Journal of Huntington's Disease. 5 (3): 217–237. doi:10.3233/JHD-160205. PMC 5310831. PMID 27662334.
Nopoulos PC (March 2016). "Huntington disease: a single-gene degenerative disorder of the striatum". Dialogues in Clinical Neuroscience. 18 (1): 91–98. doi:10.31887/DCNS.2016.18.1/pnopoulos. PMC 4826775. PMID 27069383.
Purves D, Augustine GA, Fitzpatrick D, Hall W, LaMantia AS, McNamara JO, et al. (2001). "Modulation of Movement by the Basal Ganglia – Circuits within the Basal Ganglia System". In Purves D (ed.). Neuroscience (2nd ed.). Sunderland, MA: Sinauer Associates. ISBN 978-0-87893-742-4. Archived from the original on 18 February 2009. Retrieved 1 April 2009.
Lobsiger CS, Cleveland DW (November 2007). "Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease". Nature Neuroscience. 10 (11): 1355–1360. doi:10.1038/nn1988. PMC 3110080. PMID 17965655.
Crossman AR (May 2000). "Functional anatomy of movement disorders". Journal of Anatomy. 196 (Pt 4): 519–525. doi:10.1046/j.1469-7580.2000.19640519.x. PMC 1468094. PMID 10923984.
Myers RH (April 2004). "Huntington's disease genetics". NeuroRx. 1 (2): 255–262. doi:10.1602/neurorx.1.2.255. PMC 534940. PMID 15717026.
Baig SS, Strong M, Rosser E, Taverner NV, Glew R, Miedzybrodzka Z, et al. (October 2016). "22 Years of predictive testing for Huntington's disease: the experience of the UK Huntington's Prediction Consortium". European Journal of Human Genetics. 24 (10): 1396–1402. doi:10.1038/ejhg.2016.36. PMC 5027682. PMID 27165004.
Erwin C, Williams JK, Juhl AR, Mengeling M, Mills JA, Bombard Y, et al. (July 2010). "Perception, experience, and response to genetic discrimination in Huntington disease: the international RESPOND-HD study". American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics. 153B (5): 1081–1093. doi:10.1002/ajmg.b.31079. PMC 3593716. PMID 20468061.
Losekoot M, van Belzen MJ, Seneca S, Bauer P, Stenhouse SA, Barton DE (May 2013). "EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease". European Journal of Human Genetics. 21 (5): 480–486. doi:10.1038/ejhg.2012.200. PMC 3641377. PMID 22990145.
Coppen EM, Roos RA (January 2017). "Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease". Drugs. 77 (1): 29–46. doi:10.1007/s40265-016-0670-4. PMC 5216093. PMID 27988871.
Llamas E, Koyuncu S, Lee HJ, Wehrmann M, Gutierrez-Garcia R, Dunken N, et al. (November 2023). "In planta expression of human polyQ-expanded huntingtin fragment reveals mechanisms to prevent disease-related protein aggregation". Nature Aging. 3 (11): 1345–1357. doi:10.1038/s43587-023-00502-1. PMC 10645592. PMID 37783816.
Harper PS (June 1999). "Huntington's disease: a clinical, genetic and molecular model for polyglutamine repeat disorders". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 354 (1386): 957–61. doi:10.1098/rstb.1999.0446. PMC 1692597. PMID 10434293.
Di Maio L, Squitieri F, Napolitano G, Campanella G, Trofatter JA, Conneally PM (April 1993). "Suicide risk in Huntington's disease". Journal of Medical Genetics. 30 (4): 293–5. doi:10.1136/jmg.30.4.293. PMC 1016335. PMID 8487273.
Evans SJ, Douglas I, Rawlins MD, Wexler NS, Tabrizi SJ, Smeeth L (October 2013). "Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records". Journal of Neurology, Neurosurgery, and Psychiatry. 84 (10): 1156–60. doi:10.1136/jnnp-2012-304636. PMC 3786631. PMID 23482661.
Conneally PM (May 1984). "Huntington disease: genetics and epidemiology". American Journal of Human Genetics. 36 (3): 506–26. PMC 1684448. PMID 6233902.
Bertram L, Tanzi RE (June 2005). "The genetic epidemiology of neurodegenerative disease". The Journal of Clinical Investigation. 115 (6): 1449–1457. doi:10.1172/JCI24761. PMC 1137006. PMID 15931380.
Davenport CB (May 1915). "Huntington's Chorea in Relation to Heredity and Eugenics". Proceedings of the National Academy of Sciences of the United States of America. 1 (5): 283–5. Bibcode:1915PNAS....1..283D. doi:10.1073/pnas.1.5.283. PMC 1090803. PMID 16575999.
Doerflinger RM (February 2008). "The problem of deception in embryonic stem cell research". Cell Proliferation. 41 (Suppl 1): 65–70. doi:10.1111/j.1365-2184.2008.00492.x. PMC 6496399. PMID 18181947.
Chapman MA (July 1990). "Predictive testing for adult-onset genetic disease: ethical and legal implications of the use of linkage analysis for Huntington disease". American Journal of Human Genetics. 47 (1): 1–3. PMC 1683745. PMID 2140926.
Huggins M, Bloch M, Kanani S, Quarrell OW, Theilman J, Hedrick A, et al. (July 1990). "Ethical and legal dilemmas arising during predictive testing for adult-onset disease: the experience of Huntington disease". American Journal of Human Genetics. 47 (1): 4–12. PMC 1683755. PMID 1971997.
Binedell J, Soldan JR, Scourfield J, Harper PS (November 1996). "Huntington's disease predictive testing: the case for an assessment approach to requests from adolescents". Journal of Medical Genetics. 33 (11): 912–8. doi:10.1136/jmg.33.11.912. PMC 1050784. PMID 8950670.
Wild EJ, Tabrizi SJ (September 2014). "Targets for future clinical trials in Huntington's disease: what's in the pipeline?". Movement Disorders. 29 (11): 1434–45. doi:10.1002/mds.26007. PMC 4265300. PMID 25155142.
Munoz-Sanjuan I, Bates GP (February 2011). "The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease". The Journal of Clinical Investigation. 121 (2): 476–83. doi:10.1172/JCI45364. PMC 3026740. PMID 21285520.
McBride JL, Pitzer MR, Boudreau RL, Dufour B, Hobbs T, Ojeda SR, et al. (December 2011). "Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease". Molecular Therapy. 19 (12): 2152–62. doi:10.1038/mt.2011.219. PMC 3242667. PMID 22031240.
Kordasiewicz HB, Stanek LM, Wancewicz EV, Mazur C, McAlonis MM, Pytel KA, et al. (June 2012). "Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis". Neuron. 74 (6): 1031–44. doi:10.1016/j.neuron.2012.05.009. PMC 3383626. PMID 22726834.
Wild EJ, Boggio R, Langbehn D, Robertson N, Haider S, Miller JR, et al. (May 2015). "Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients". The Journal of Clinical Investigation. 125 (5): 1979–86. doi:10.1172/jci80743. PMC 4463213. PMID 25844897.
Keiser MS, Kordasiewicz HB, McBride JL (April 2016). "Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia". Human Molecular Genetics. 25 (R1): R53–64. doi:10.1093/hmg/ddv442. PMC 4802374. PMID 26503961.
Bhattacharyya A, Trotta CR, Narasimhan J, Wiedinger KJ, Li W, Effenberger KA, et al. (15 December 2021). "Small molecule splicing modifiers with systemic HTT-lowering activity". Nature Communications. 12 (1): 7299. Bibcode:2021NatCo..12.7299B. doi:10.1038/s41467-021-27157-z. ISSN 2041-1723. PMC 8674292. PMID 34911927.
Holley SM, Kamdjou T, Reidling JC, Fury B, Coleal-Bergum D, Bauer G, et al. (April 2018). "Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings". CNS Neuroscience & Therapeutics. 24 (4). Wiley: 329–342. doi:10.1111/cns.12839. PMC 6489814. PMID 29512295.
Cundiff PE, Anderson SA (June 2011). "Impact of induced pluripotent stem cells on the study of central nervous system disease". Current Opinion in Genetics & Development. 21 (3): 354–61. doi:10.1016/j.gde.2011.01.008. PMC 3932563. PMID 21277194.
Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. (October 2017). "Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease". Cell. 171 (2): 273–285. doi:10.1016/j.cell.2017.09.021. PMC 5685180. PMID 28985560.

ninds.nih.gov

"Huntington's Disease Information Page". National Institute of Neurological Disorders and Stroke. Archived from the original on 13 December 2020. Retrieved 14 December 2020.
"Huntington's Disease: Hope Through Research". www.ninds.nih.gov. Archived from the original on 25 October 2020. Retrieved 16 November 2020.

nytimes.com

Smith JE, Cordero C (23 May 2023). "Sought Out by Science, and Then Forgotten". The New York Times. Archived from the original on 23 May 2023. Retrieved 23 May 2023.

predictivetestingforhd.com

"Predictive Testing for Huntington's Disease". 2011. Archived from the original on 22 January 2013. Retrieved 7 May 2013.

radpod.org

Gaillard F (1 May 2007). "Huntington's disease". Radiology picture of the day. www.radpod.org. Archived from the original on 22 October 2007. Retrieved 24 July 2009.

semanticscholar.org

api.semanticscholar.org

Illarioshkin SN, Klyushnikov SA, Vigont VA, Seliverstov YA, Kaznacheyeva EV (September 2018). "Molecular Pathogenesis in Huntington's Disease". Biochemistry. Biokhimiia. 83 (9): 1030–1039. doi:10.1134/S0006297918090043. PMID 30472941. S2CID 26471825. Archived from the original on 13 November 2020. Retrieved 8 November 2020 – via protein.bio.msu.ru.
Saudou F, Humbert S (March 2016). "The Biology of Huntingtin". Neuron. 89 (5): 910–926. doi:10.1016/j.neuron.2016.02.003. PMID 26938440. S2CID 8272667.
Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, et al. (April 2015). "Huntington disease". Nature Reviews. Disease Primers. 1: 15005. doi:10.1038/nrdp.2015.5. PMID 27188817. S2CID 25759303.
Walker FO (January 2007). "Huntington's disease". Lancet. 369 (9557): 218–228. doi:10.1016/S0140-6736(07)60111-1. PMID 17240289. S2CID 46151626.
Aziz NA, van der Marck MA, Pijl H, Olde Rikkert MG, Bloem BR, Roos RA (December 2008). "Weight loss in neurodegenerative disorders". Journal of Neurology. 255 (12): 1872–1880. doi:10.1007/s00415-009-0062-8. PMID 19165531. S2CID 26109381.
van der Burg JM, Björkqvist M, Brundin P (August 2009). "Beyond the brain: widespread pathology in Huntington's disease". The Lancet. Neurology. 8 (8): 765–774. doi:10.1016/S1474-4422(09)70178-4. PMID 19608102. S2CID 14419437.
Squitieri F, Frati L, Ciarmiello A, Lastoria S, Quarrell O (February 2006). "Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease?". Mechanisms of Ageing and Development. 127 (2): 208–212. doi:10.1016/j.mad.2005.09.012. PMID 16274727. S2CID 20523093.
Semaka A, Creighton S, Warby S, Hayden MR (October 2006). "Predictive testing for Huntington disease: interpretation and significance of intermediate alleles". Clinical Genetics. 70 (4): 283–294. doi:10.1111/j.1399-0004.2006.00668.x. PMID 16965319. S2CID 26007984.
Wexler NS, Young AB, Tanzi RE, Travers H, Starosta-Rubinstein S, Penney JB, et al. (1987). "Homozygotes for Huntington's disease". Nature. 326 (6109): 194–197. Bibcode:1987Natur.326..194W. doi:10.1038/326194a0. hdl:2027.42/62543. PMID 2881213. S2CID 4312171.
Cattaneo E, Zuccato C, Tartari M (December 2005). "Normal huntingtin function: an alternative approach to Huntington's disease". Nature Reviews. Neuroscience. 6 (12): 919–930. doi:10.1038/nrn1806. PMID 16288298. S2CID 10119487.
Rubinsztein DC, Carmichael J (August 2003). "Huntington's disease: molecular basis of neurodegeneration". Expert Reviews in Molecular Medicine. 5 (20): 1–21. doi:10.1017/S1462399403006549. PMID 14585171. S2CID 28435830.
Matlahov I, van der Wel PC (December 2019). "Conformational studies of pathogenic expanded polyglutamine protein deposits from Huntington's disease". Experimental Biology and Medicine. 244 (17): 1584–1595. doi:10.1177/1535370219856620. PMC 6920524. PMID 31203656. S2CID 189944779.
Sadri-Vakili G, Cha JH (June 2006). "Mechanisms of disease: Histone modifications in Huntington's disease". Nature Clinical Practice. Neurology. 2 (6): 330–338. doi:10.1038/ncpneuro0199. PMID 16932577. S2CID 12474262.
Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, et al. (October 2001). "Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila". Nature. 413 (6857): 739–743. Bibcode:2001Natur.413..739S. doi:10.1038/35099568. PMID 11607033. S2CID 4419980. Archived from the original on 1 August 2020. Retrieved 28 June 2019.
Forrest Keenan K, Simpson SA, Miedzybrodzka Z, Alexander DA, Semper J (June 2013). "How do partners find out about the risk of Huntington's disease in couple relationships?". Journal of Genetic Counseling. 22 (3): 336–344. doi:10.1007/s10897-012-9562-2. PMID 23297124. S2CID 15447709.
Smith JA, Michie S, Stephenson M, Quarrell O (March 2002). "Risk Perception and Decision-making Processes in Candidates for Genetic Testing for Huntington's Disease: An Interpretative Phenomenological Analysis". Journal of Health Psychology. 7 (2): 131–144. doi:10.1177/1359105302007002398. PMID 22114233. S2CID 40182214.
Hayden MR (March 2003). "Predictive testing for Huntington's disease: a universal model?". The Lancet. Neurology. 2 (3): 141–142. doi:10.1016/S1474-4422(03)00317-X. PMID 12849232. S2CID 39581496.
"Guidelines for the molecular genetics predictive test in Huntington's disease. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea". Neurology. 44 (8): 1533–1536. August 1994. doi:10.1212/WNL.44.8.1533. PMID 8058167. S2CID 28018134.
Schulman JD, Black SH, Handyside A, Nance WE (February 1996). "Preimplantation genetic testing for Huntington disease and certain other dominantly inherited disorders". Clinical Genetics. 49 (2): 57–58. doi:10.1111/j.1399-0004.1996.tb04327.x. PMID 8740912. S2CID 45703511.
Stern HJ, Harton GL, Sisson ME, Jones SL, Fallon LA, Thorsell LP, et al. (June 2002). "Non-disclosing preimplantation genetic diagnosis for Huntington disease". Prenatal Diagnosis. 22 (6): 503–507. doi:10.1002/pd.359. PMID 12116316. S2CID 33967835.
Kuliev A, Verlinsky Y (April 2005). "Preimplantation diagnosis: a realistic option for assisted reproduction and genetic practice". Current Opinion in Obstetrics & Gynecology. 17 (2): 179–183. doi:10.1097/01.gco.0000162189.76349.c5. PMID 15758612. S2CID 9382420.
Schneider SA, Walker RH, Bhatia KP (September 2007). "The Huntington's disease-like syndromes: what to consider in patients with a negative Huntington's disease gene test". Nature Clinical Practice. Neurology. 3 (9): 517–525. doi:10.1038/ncpneuro0606. PMID 17805246. S2CID 9052603.
Frank S, Jankovic J (March 2010). "Advances in the pharmacological management of Huntington's disease". Drugs. 70 (5): 561–571. doi:10.2165/11534430-000000000-00000. PMID 20329804. S2CID 42386743. Archived from the original on 8 October 2011.
Bonelli RM, Wenning GK, Kapfhammer HP (March 2004). "Huntington's disease: present treatments and future therapeutic modalities". International Clinical Psychopharmacology. 19 (2): 51–62. doi:10.1097/00004850-200403000-00001. PMID 15076012. S2CID 1956458.
Morsy S, Khalil SM, Doheim MF, Kamel MG, El-Basiony DS, Ahmed Hassan HI, et al. (August 2019). "Efficacy of ethyl-EPA as a treatment for Huntington disease: a systematic review and meta-analysis". Acta Neuropsychiatrica. 31 (4): 175–185. doi:10.1017/neu.2019.11. hdl:10069/39427. PMID 30890195. S2CID 84183892.
Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, et al. (August 1993). "The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease". Nature Genetics. 4 (4): 398–403. doi:10.1038/ng0893-398. PMID 8401589. S2CID 20645822.
Walker FO (January 2007). "Huntington's disease". Lancet. 369 (9557): 218–28. doi:10.1016/S0140-6736(07)60111-1. PMID 17240289. S2CID 46151626.
Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, et al. (1983). "A polymorphic DNA marker genetically linked to Huntington's disease". Nature. 306 (5940): 234–8. Bibcode:1983Natur.306..234G. doi:10.1038/306234a0. PMID 6316146. S2CID 4320711.
Sveinsson O, Halldórsson S, Olafsson E (July 2012). "An unusually low prevalence of Huntington's disease in Iceland". European Neurology. 68 (1): 48–51. doi:10.1159/000337680. PMID 22722209. S2CID 207551998.
Almqvist EW, Elterman DS, MacLeod PM, Hayden MR (September 2001). "High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia". Clinical Genetics. 60 (3): 198–205. doi:10.1034/j.1399-0004.2001.600305.x. PMID 11595021. S2CID 19786394.
Lanska DJ (April 2000). "George Huntington (1850–1916) and hereditary chorea". Journal of the History of the Neurosciences. 9 (1): 76–89. doi:10.1076/0964-704X(200004)9:1;1-2;FT076. PMID 11232352. S2CID 22659368.
Vessie PR (1932). "On the transmission of Huntington's chorea for 300 years – the Bures family group". Nervous and Mental Disease. 76 (6): 553–573. doi:10.1097/00005053-193212000-00001. S2CID 147656032. Archived from the original on 28 August 2021. Retrieved 1 April 2009.
Wexler AR (2002). "Chorea and community in a nineteenth-century town". Bulletin of the History of Medicine. 76 (3): 495–527. doi:10.1353/bhm.2002.0150. PMID 12486915. S2CID 30791504.
"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group". Cell. 72 (6): 971–983. March 1993. doi:10.1016/0092-8674(93)90585-E. hdl:2027.42/30901. PMID 8458085. S2CID 802885.
La Spada AR, Roling DB, Harding AE, Warner CL, Spiegel R, Hausmanowa-Petrusewicz I, et al. (December 1992). "Meiotic stability and genotype–phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy". Nature Genetics. 2 (4): 301–4. doi:10.1038/ng1292-301. PMID 1303283. S2CID 6603129.
Ross CA, Tabrizi SJ (January 2011). "Huntington's disease: from molecular pathogenesis to clinical treatment". The Lancet. Neurology. 10 (1): 83–98. doi:10.1016/S1474-4422(10)70245-3. PMID 21163446. S2CID 17488174.
Rollin BE (2006). "The regulation of animal research and the emergence of animal ethics: a conceptual history" (PDF). Theoretical Medicine and Bioethics. 27 (4): 285–304. doi:10.1007/s11017-006-9007-8. PMID 16937023. S2CID 18620094. Archived from the original (PDF) on 8 October 2020. Retrieved 1 December 2019.
Braude PR, De Wert GM, Evers-Kiebooms G, Pettigrew RA, Geraedts JP (December 1998). "Non-disclosure preimplantation genetic diagnosis for Huntington's disease: practical and ethical dilemmas". Prenatal Diagnosis. 18 (13): 1422–6. doi:10.1002/(SICI)1097-0223(199812)18:13<1422::AID-PD499>3.0.CO;2-R. PMID 9949442. S2CID 39977672.
Odling-Smee L (17 May 2007). "Biomedical philanthropy: The money tree". Nature. 447 (7142): 251. Bibcode:2007Natur.447..251.. doi:10.1038/447251a. S2CID 4357517.
Check E (May 2007). "Biomedical philanthropy: love or money". Nature. 447 (7142): 252–3. Bibcode:2007Natur.447..252C. doi:10.1038/447252a. PMID 17507955. S2CID 4318384.
Chase A (May 2015). "Huntington disease: cerebrospinal fluid and MRI biomarkers for prodromal HD". Nature Reviews Neurology. 11 (5): 245. doi:10.1038/nrneurol.2015.63. PMID 25896083. S2CID 38300571.
Kwon D (6 April 2021). "Genetic therapies offer new hope against incurable brain diseases". Nature. 592 (7853): 180–183. Bibcode:2021Natur.592..180K. doi:10.1038/d41586-021-00870-x. PMID 33824521. S2CID 233173862.
Djajadikerta A, Keshri S, Pavel M, Prestil R, Ryan L, Rubinsztein DC (April 2020). "Autophagy Induction as a Therapeutic Strategy for Neurodegenerative Diseases". Journal of Molecular Biology. Autophagy in Neurodegenerative Diseases. 432 (8): 2799–2821. doi:10.1016/j.jmb.2019.12.035. PMID 31887286. S2CID 209518157. Archived from the original on 23 May 2022. Retrieved 20 June 2023.
Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, et al. (June 2004). "Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease". Nature Genetics. 36 (6): 585–595. doi:10.1038/ng1362. PMID 15146184. S2CID 7749825.

timesofisrael.com

Solomon S (3 May 2017). "Taube to fund $3m Huntington's disease research in US". The Times of Israel. Archived from the original on 3 May 2017. Retrieved 5 May 2017.

uib.no

org.uib.no

Rollin BE (2006). "The regulation of animal research and the emergence of animal ethics: a conceptual history" (PDF). Theoretical Medicine and Bioethics. 27 (4): 285–304. doi:10.1007/s11017-006-9007-8. PMID 16937023. S2CID 18620094. Archived from the original (PDF) on 8 October 2020. Retrieved 1 December 2019.

unl.edu

dwb4.unl.edu

"Guidelines for Genetic Testing for Huntington's Disease". Heredity Disease Foundation. Archived from the original on 26 June 2015. Retrieved 7 May 2013.

web.archive.org

"Huntington's Disease Information Page". National Institute of Neurological Disorders and Stroke. Archived from the original on 13 December 2020. Retrieved 14 December 2020.
"Huntington's disease - Treatment and support". National Health Service UK. 23 October 2017. Archived from the original on 6 May 2023. Retrieved 6 May 2023.
Illarioshkin SN, Klyushnikov SA, Vigont VA, Seliverstov YA, Kaznacheyeva EV (September 2018). "Molecular Pathogenesis in Huntington's Disease". Biochemistry. Biokhimiia. 83 (9): 1030–1039. doi:10.1134/S0006297918090043. PMID 30472941. S2CID 26471825. Archived from the original on 13 November 2020. Retrieved 8 November 2020 – via protein.bio.msu.ru.
"Aspiration Pneumonia: What It Is, Causes, Diagnosis, Treatment". Cleveland Clinic. Archived from the original on 12 June 2023. Retrieved 12 June 2023.
"About Huntington's Disease". Genome.gov. Archived from the original on 9 January 2021. Retrieved 13 January 2021.
"History of the HDF". Hereditary Disease Foundation. Archived from the original on 19 November 2015. Retrieved 18 November 2015.
"History and Genetics of Huntington's Disease | Huntington's Disease Society of America". March 2019. Archived from the original on 1 December 2020. Retrieved 14 December 2020.
"Huntington's disease - Symptoms and causes". Mayo Clinic. Archived from the original on 5 March 2018. Retrieved 13 December 2022.
"Huntington's disease". www.nhsinform.scot. Archived from the original on 12 July 2020. Retrieved 12 July 2020.
Caron NS, Wright GE, Hayden MR (June 2020). "Huntington Disease". Genereviews Bookshelf. University of Washington. PMID 20301482. Archived from the original on 10 February 2009. Retrieved 22 November 2020.
Montoya A, Price BH, Menear M, Lepage M (January 2006). "Brain imaging and cognitive dysfunctions in Huntington's disease" (PDF). Journal of Psychiatry & Neuroscience. 31 (1): 21–29. PMC 1325063. PMID 16496032. Archived from the original (PDF) on 23 March 2016. Retrieved 17 September 2008.
"Booklet by the Huntington Society of Canada" (PDF). Caregiver's Handbook for Advanced-Stage Huntington Disease. HD Society of Canada. 11 April 2007. Archived from the original (PDF) on 25 June 2008. Retrieved 10 August 2008.
"Sex Linked". Genome.gov. Archived from the original on 14 April 2022. Retrieved 13 December 2022.
Purves D, Augustine GA, Fitzpatrick D, Hall W, LaMantia AS, McNamara JO, et al. (2001). "Modulation of Movement by the Basal Ganglia – Circuits within the Basal Ganglia System". In Purves D (ed.). Neuroscience (2nd ed.). Sunderland, MA: Sinauer Associates. ISBN 978-0-87893-742-4. Archived from the original on 18 February 2009. Retrieved 1 April 2009.
Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, et al. (October 2001). "Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila". Nature. 413 (6857): 739–743. Bibcode:2001Natur.413..739S. doi:10.1038/35099568. PMID 11607033. S2CID 4419980. Archived from the original on 1 August 2020. Retrieved 28 June 2019.
Gaillard F (1 May 2007). "Huntington's disease". Radiology picture of the day. www.radpod.org. Archived from the original on 22 October 2007. Retrieved 24 July 2009.
"Unified Huntington's Disease Rating Scale (UHDRS)". UHDRS and Database. HSG. 1 February 2009. Archived from the original on 11 August 2015. Retrieved 14 April 2009.
"Predictive Testing for Huntington's Disease". 2011. Archived from the original on 22 January 2013. Retrieved 7 May 2013.
"Guidelines for Genetic Testing for Huntington's Disease". Heredity Disease Foundation. Archived from the original on 26 June 2015. Retrieved 7 May 2013.
Frank S, Jankovic J (March 2010). "Advances in the pharmacological management of Huntington's disease". Drugs. 70 (5): 561–571. doi:10.2165/11534430-000000000-00000. PMID 20329804. S2CID 42386743. Archived from the original on 8 October 2011.
"EHDN Physiotherapy Guidance Document" (PDF). European HD Network Physiotherapy Working Group. Archived from the original (PDF) on 4 March 2016. Retrieved 15 November 2015.
Quin L, Busee M (February 2012). "Development of physiotherapy guidance and treatment-based classifications for people with Huntington's disease". Neurodegenerative Disease Management. 2 (1): 21–31. doi:10.2217/nmt.11.86. Archived from the original on 9 August 2020. Retrieved 10 May 2012.
"FDA Approves First Drug for Treatment of Chorea in Huntington's Disease". U.S. Food and Drug Administration. 15 August 2008. Archived from the original on 21 August 2008. Retrieved 10 August 2008.
Center for Drug Evaluation Research (17 July 2019). "In Pursuit of Tardive Dyskinesia: The Breakthrough Designation and Approval of Valbenazine". FDA. Archived from the original on 3 December 2020. Retrieved 15 November 2020.
Sharon I, Sharon R, Wilkens JP, Ersan T (2010). "Huntington Disease Dementia". emedicine, WebMD. Medscape. Archived from the original on 5 March 2010. Retrieved 16 May 2010.
Huntington G (1872). "On Chorea". Medical and Surgical Reporter of Philadelphia. 26 (15): 317–321. ISBN 978-90-6186-011-2. Archived from the original on 21 April 2022. Retrieved 21 April 2022.
Dunglison R (1842). The Practice of Medicine ... Vol. 2. Philadelphia, Pennsylvania, USA: Lea & Blanchard. pp. 312–313. Archived from the original on 20 April 2022. Retrieved 20 April 2022.
Gorman CR (1846). On a Form of Chorea, Vulgarly called Magrums (Doctor of Medicine thesis). Philadelphia: Jefferson Medical College.
- "Catalogue of Jefferson Medical College of Philadelphia: Session of 1846-7". p. 14. Archived from the original on 26 June 2022.
- Osler W (1908). "Historical notes on hereditary chorea". Neurographs. 1 (2): 113–116. Archived from the original on 21 April 2022. Retrieved 21 April 2022. See p. 115.
  - See also: Osler W (February 1893). "Remarks on the varieties of chronic chorea, and a report upon two families of the hereditary form, with one autopsy". The Journal of Nervous and Mental Disease. 20 (2): 97–111. Archived from the original on 21 April 2022. Retrieved 21 April 2022.
  - Jelliffe SE, Muncey EB, Davenport CB (1913). "Huntington's Chorea: A Study in Heredity". The Journal of Nervous and Mental Disease. 40 (12): 796–799. doi:10.1097/00005053-191312000-00010. Archived from the original on 5 April 2022. Retrieved 19 September 2020.
  - Vessie PR (1932). "On the transmission of Huntington's chorea for 300 years – the Bures family group". Nervous and Mental Disease. 76 (6): 553–573. doi:10.1097/00005053-193212000-00001. S2CID 147656032. Archived from the original on 28 August 2021. Retrieved 1 April 2009.
  - "The Venezuela Huntington's disease project". Hereditary Disease Foundation website. Hereditary Disease Foundation. 2008. Archived from the original on 10 August 2015. Retrieved 8 September 2008.
  - Smith JE, Cordero C (23 May 2023). "Sought Out by Science, and Then Forgotten". The New York Times. Archived from the original on 23 May 2023. Retrieved 23 May 2023.
  - "What is HD?". Huntington's disease association. Archived from the original on 13 December 2011. Retrieved 18 December 2011.
  - Rollin BE (2006). "The regulation of animal research and the emergence of animal ethics: a conceptual history" (PDF). Theoretical Medicine and Bioethics. 27 (4): 285–304. doi:10.1007/s11017-006-9007-8. PMID 16937023. S2CID 18620094. Archived from the original (PDF) on 8 October 2020. Retrieved 1 December 2019.
  - "Insurance Genetics Moratorium extended to 2017" (Press release). Association of British Insurers. 5 April 2011. Archived from the original on 4 March 2016. Retrieved 13 January 2016.
  - "Expert backs gene test disclosure". BBC article. 7 June 2007. Archived from the original on 26 February 2008.
  - "The International Huntington Association". International Huntington Association. 2013. Archived from the original on 18 April 2009. Retrieved 3 April 2009.
  - "US Senate s. resolution 531". S. Res. 531. US Senate. 6 April 2008. Archived from the original on 17 November 2015. Retrieved 10 August 2008.
  - "Huntington's Disease: Hope Through Research". www.ninds.nih.gov. Archived from the original on 25 October 2020. Retrieved 16 November 2020.
  - Solomon S (3 May 2017). "Taube to fund $3m Huntington's disease research in US". The Times of Israel. Archived from the original on 3 May 2017. Retrieved 5 May 2017.
  - "Scientific Publications | CHDI Foundation". chdifoundation.org. Archived from the original on 12 December 2021. Retrieved 12 December 2021.
  - "CHDI Foundation". chdifoundation.org. Archived from the original on 14 November 2020. Retrieved 13 November 2020.
  - "Landmark Huntington's trial starts". Archived from the original on 21 October 2015. Retrieved 19 October 2015.
  - "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-HTTRx in Patients With Early Manifest Huntington's Disease - Full Text View". ClinicalTrials.gov. Archived from the original on 29 September 2015. Retrieved 18 April 2016.
  - Harding R (26 April 2021). Fox L (ed.). "Huntington's disease clinical trial round up". HDBuzz. Archived from the original on 5 May 2021. Retrieved 5 May 2021.
  - Djajadikerta A, Keshri S, Pavel M, Prestil R, Ryan L, Rubinsztein DC (April 2020). "Autophagy Induction as a Therapeutic Strategy for Neurodegenerative Diseases". Journal of Molecular Biology. Autophagy in Neurodegenerative Diseases. 432 (8): 2799–2821. doi:10.1016/j.jmb.2019.12.035. PMID 31887286. S2CID 209518157. Archived from the original on 23 May 2022. Retrieved 20 June 2023.
  - "Search of: Huntington Disease - List Results - ClinicalTrials.gov". clinicaltrials.gov. Archived from the original on 11 November 2021. Retrieved 16 November 2020.
  - "Completed Clinical Trials". Huntington Study Group. Archived from the original on 28 June 2012. Retrieved 4 February 2012.

wellcomecollection.org

Osler W (1908). "Historical notes on hereditary chorea". Neurographs. 1 (2): 113–116. Archived from the original on 21 April 2022. Retrieved 21 April 2022. See p. 115.
- See also: Osler W (February 1893). "Remarks on the varieties of chronic chorea, and a report upon two families of the hereditary form, with one autopsy". The Journal of Nervous and Mental Disease. 20 (2): 97–111. Archived from the original on 21 April 2022. Retrieved 21 April 2022.

worldcat.org

search.worldcat.org

Avila-Giróo R (1973). "Medical and Social Aspects of Huntington's chorea in the state of Zulia, Venezuela". Advances in Neurology. 1: 261–6. ISSN 0091-3952. NAID 10021247802.
Bhattacharyya A, Trotta CR, Narasimhan J, Wiedinger KJ, Li W, Effenberger KA, et al. (15 December 2021). "Small molecule splicing modifiers with systemic HTT-lowering activity". Nature Communications. 12 (1): 7299. Bibcode:2021NatCo..12.7299B. doi:10.1038/s41467-021-27157-z. ISSN 2041-1723. PMC 8674292. PMID 34911927.

zenodo.org

Jelliffe SE, Muncey EB, Davenport CB (1913). "Huntington's Chorea: A Study in Heredity". The Journal of Nervous and Mental Disease. 40 (12): 796–799. doi:10.1097/00005053-191312000-00010. Archived from the original on 5 April 2022. Retrieved 19 September 2020.